0001520138-20-000428.txt : 20200915 0001520138-20-000428.hdr.sgml : 20200915 20200915141825 ACCESSION NUMBER: 0001520138-20-000428 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200915 DATE AS OF CHANGE: 20200915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREY CLOAK TECH INC. CENTRAL INDEX KEY: 0001630176 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 472594704 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55572 FILM NUMBER: 201175725 BUSINESS ADDRESS: STREET 1: 6445 SOUTH TENAYA WAY STREET 2: SUITE B110 CITY: LAS VEGAS STATE: NV ZIP: 89113 BUSINESS PHONE: (720) 463-1004 MAIL ADDRESS: STREET 1: 6445 SOUTH TENAYA WAY STREET 2: SUITE B110 CITY: LAS VEGAS STATE: NV ZIP: 89113 10-Q 1 grck-20200630_10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission file number 000-55572

Grey Cloak Tech Inc.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction of

incorporation or organization)

47-2594704

(I.R.S. Employer

Identification No.)

10300 W. Charleston

Las Vegas, NV

(Address of principal executive offices)

89135

(Zip Code)

Registrant’s telephone number, including area code (702) 201-6450

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the previous 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
(Do not check if a smaller reporting company)		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of September 14, 2020, there were 299,887,410 shares of common stock, $0.001 par value, issued and outstanding.

GREY CLOAK TECH INC.

TABLE OF CONTENTS

		Page
PART I – FINANCIAL INFORMATION		1

	Item 1. Financial Statements	2
	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	20
	Item 3. Quantitative and Qualitative Disclosure About Market Risks	25
	Item 4. Controls and Procedures	25

PART II – OTHER INFORMATION		26

	Item 1. Legal Proceedings	26
	Item 1.ARisk Factors	26
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	26
	Item 3. Defaults Upon Senior Securities	26
	Item 4. Mine Safety Disclosures	26
	Item 5. Other Information	26
	Item 6. Exhibits	27

SIGNATURES		28

PART I – FINANCIAL INFORMATION

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934 (the “Exchange Act”). These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading: “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider” or similar expressions are used.

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

-1-

Table of Contents

ITEM 1

Financial Statements

-2-

Table of Contents

GREY CLOAK TECH INC

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	JUNE 30, 2020			DECEMBER 31, 2019
ASSETS

CURRENT ASSETS
Cash	$	664,156		$	133,451
Accounts receivable		15,862			26,473
Inventory		3,061,796			3,081,158
Note receivable		—			—
Accrued interest receivable		—			—
Total current assets		3,741,814			3,241,083

Fixed assets, net of accumulated depreciation of $39,207 and $36,895, respectively		10,560			15,183
Website, net of accumulated amortization of $2,800 and $2,800, respectively		—			—
Patents/Trademarks		336,891			—
Deposit		—			—
Goodwill		193,260			193,260
Total other assets		540,711			208,443

TOTAL ASSETS	$	4,282,525		$	3,449,526


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

LIABILITIES
Accounts payable	$	44,270		$	21,125
Accounts payable - related party		—			—
Accrued liabilities		54,122			53,341
Notes payable		79,667			79,667
Notes payable - related party		1,050,866			1,050,866
Convertible debt, net of discount of $0.00 and $0.00, respectively		166,750			166,750
Convertible debt - related party, net of discount of $0.00 and $0.00, respectively		—			1,341,876
Accrued interest payable		60,455			49,902
Accrued interest payable - related party		480,217			491,221
Derivative liabilities		1,917,723			1,060,388
Total current and total liabilities		3,854,070			4,315,136


STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.001 par value, 75,000,000 shares authorized, none and none shares issued and outstanding, respectively		—			—
Common stock, $0.001 par value, 2,500,000,000 shares authorized, 264,059,759 and 121,610,085 shares issued and outstanding, respectively		264,060			121,610
Additional paid-in capital		13,304,881			9,392,903
Accumulated deficit		(13,140,485	)		(10,380,123	)
Total stockholders' equity (deficit)		428,456			(865,610	)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	4,282,525		$	3,449,526

The accompanying notes are an integral part of these unaudited consolidated financial statements.

-3-

Table of Contents

GREY CLOAK TECH INC

CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDING JUNE 30, 2020 AND 2019

(Unaudited)

	FOR THE THREE MONTHS ENDED JUNE 30						FOR THE SIX MONTHS ENDED JUNE 30
	2020			2019			2020			2019

REVENUE	$	151,719		$	201,040		$	607,558		$	298,313

COST OF REVENUE		20,589			46,241			216,646			78,004

GROSS PROFIT		131,130			154,799			390,912			220,308

OPERATING EXPENSES
General and administrative		444,318			300,109			651,950			562,625
Total operating expenses		444,318			300,109			651,950			562,625

OTHER INCOME (EXPENSE)
Interest expense, net of interest income		(19,631	)		(19,675	)		(62,107	)		(32,539	)
Change in fair value on derivative		(1,472,471	)		(113,407	)		(857,335	)		1,636,029
Loss on extinguishment of debt		—			—			—			53,038
Impairment of Assets		(1,579,883	)		—			(1,579,883	)		—
Gain on sale of asset		—			—			—			—

Total other income (expense)		(3,071,985	)		(133,082	)		(2,499,325	)		1,656,528

Net gain/(loss) before income tax provision		(3,385,173	)		(278,392	)		(2,760,363	)		1,314,212

NET GAIN/(LOSS)	$	(3,385,173	)	$	(278,392	)	$	(2,760,363	)	$	1,314,212


Loss per share - basic and diluted	$	(0.02	)	$	(0.00	)	$	(0.01	)	$	0.01

Weighted average number of shares outstanding - basic and diluted		182,890,767			98,883,192			223,697,036			110,612,376

The accompanying notes are an integral part of these unaudited consolidated financial statements.

-4-

Table of Contents

GREY CLOAK TECH INC

CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

	FOR THE SIX MONTHS ENDING
	JUNE 30
	2020			2019
Cash Flows from Operating Activities:
Net Gain/(Loss)	$	(2,760,363	)	$	1,592,604

Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization		4,623			1,614
Warrants issued for services		—			7,000
Non-cash compensation		—			108,260
Change in fair value on derivative liability		857,335			(1,941,315	)
Loss on extinguishment of debt		—			53,038
Changes in operating assets and liabilities:
Accounts receivable		10,611			(27,157	)
Inventory		19,362			(2,343,328	)
Accrued interest receivable		—			4,762
Accounts payable		23,145			(11,240	)
Accounts payable - related party		—			(15,000	)
Accrued liabilities		781			—
Accrued interest payable		10,553			393,558
Accrued interest payable - related party		(11,004	)		769
Net Cash used in Operating Activities		(1,844,956	)		(2,176,435	)

Cash Flows from Investing Activities:

Purchase of fixed assets		—			(22,985	)
Purchase of note receivable		—			79,295
Purchase of BergaMet		—			1,907,010
Purchase of UBN		(336,891	)		1,907,010
Cash flows provided by (used in) Investing Activities:		(336,891	)		3,870,331

Cash Flows from Financing Activities:

Proceeds from issuance of common stock		4,054,428
Proceeds from issuance of convertible debt,		(1,341,876	)		(71,092	)
Payments for repayment of convertible debt		—			(349,330	)
Proceeds from issuance of noted payable		—			(63,000	)
Proceeds from issuance of noted payable - related party		—			1,050,700
Payments for repayment of notes payable - related party		—			(15,000	)
Liabilities assumed		—			—
Net Cash provided by Financing Activities		2,712,552			552,278

Increase (decrease) in cash		530,705			2,246,175
Cash at beginning of period		133,451			485
Cash at end of period	$	664,156		$	2,246,660

The accompanying notes are an integral part of these unaudited consolidated financial statements.

-5-

Table of Contents

GREY CLOAK TECH INC

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

FOR THE YEAR ENDING DECEMBER 2020 AND 2019

(Unaudited)

											Additional
	Preferred Stock						Common Stock				Paid-In			Accumulated
	Shares			Amount			Shares		Amount		Capital			Deficit			Total
Balance - December 31, 2018		1,333,334			1,333			6,455,354		6,455		7,440,895		$	(11,012,899	)	$	(3,564,216	)

Cashless exercise of warrants		—			—			996,052		996		1,921			—			2,917

Issuance of shares acquisition of BergaMet		—			—			97,409,678		97,410		1,850,784						1,948,194

Issuance of common stock for preferred stock conversion		(1,333,334	)		(1,333	)		15,592,986		15,593		(14,260	)		—			—

Issuance of common stock for debt conversion		—			—			806,015		806		106,912			—			107,718

Issuance of common stock for consulting fees		—			—			350,000		350		6,650			—			7,000

Debt Forgiveness		—			—			—		—		—			—			—

Net (loss) gain for the period		—			—			—		—		—			632,776			632,776

Balance - December 31, 2019		—		$	—			121,610,085	$	121,610		9,392,903		$	(10,380,123	)	$	(865,610	)

Issuance of shares acquisition of UBN		—			—			90,000,960		90,001		1,800,019			—			1,890,020

Issuance of common stock for debt conversion		—			—			39,248,714		39,249		1,465,159			—			1,504,408

Issuance of common stock for debt conversion		—			—			13,200,000		13,200		646,800			—			660,000

Net (loss) gain for the period		—			—			—		—		—			(2,760,363	)		(2,760,363	)

Balance - June 30, 2020		—		$	—			264,059,759	$	264,060		13,304,881		$	(13,140,485	)	$	428,456

The accompanying notes are an integral part of these unaudited consolidated financial statements.

-6-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

Grey Cloak Tech Inc. (the “Company”) was incorporated in the State of Nevada on December 19, 2014. The Company has additionally acquired BergaMet NA, LLC which markets and sells heath supplemental products, and Ultimate Brain Nutrients, LLC which develops plant-based neuro-products that provide natural brain solutions.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020 and the results of operations and cash flows for the periods presented. The results of operations for the six months ended June 30, 2020 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s form 10-K for the year ended December 31, 2019 filed with the SEC on August 10, 2020.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

Cash includes cash in banks, money market funds, and certificates of term deposits with maturities of less than three months from inception, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value.

Accounts Receivables

Accounts receivables are recorded at the invoice amount and do not bear interest.

Inventory

Inventories consist of health supplements held for sale in the ordinary course of business. The Company uses the weighted average cost method to value its inventories at the lower of cost or market. An allowance for inventory was established in 2018 and is evaluated each quarter to determine if all items are still sellable due to expiration dates. As of June 30, 2020 and 2019, the total of inventory which was written off as an inventory allowance was $748,972 and $324,014.

-7-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Property and Equipment

The Company’s property and equipment are recorded at cost and depreciated using the straight-line method over the useful lives of the assets, generally from three to seven years. Upon sale or disposal of property and equipment, the related asset cost and accumulated depreciation or amortization are removed from the respective accounts and any gain or loss is reflected in current operations.

Goodwill

In accordance with Goodwill and Other Intangible Assets, goodwill is defined as the excess of the purchase price over the fair value assigned to individual assets acquired and liabilities assumed and is tested for impairment at the reporting unit level on an annual basis in the Company's fourth fiscal quarter or more frequently if indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair value of the Company's reporting units with each respective reporting unit's carrying amount, including goodwill. The fair value of reporting units is generally determined using the income approach. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the second step of the goodwill impairment test is performed to determine the amount of any impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. The Company sees the goodwill to have a ten-year useful life. No goodwill impairment indicators were present, for the goodwill listed on the books as of March 31, 2020, after working through our analysis of goodwill during the months ending June 30, 2020.

The Company has determined that the method applied represents the fair value of the asset group principally because the valuation of the intangibles with the asset group is based on the anticipated cash flows related to the revenue stream from its customers. The asset group excludes goodwill, long term non-operational assets and liabilities and cash. As such, the principal value from the asset group relates to the cash inflows from its customers and the cash outflows required to service these customers. The fair value for the asset group consists of the following:

Fair value of net revenues: computed using the income approach. The key input to these computations is the anticipated cash inflows from customers. These valuations include 100% of the cash inflows related to the customer base, and taking cash outflows into consideration.

Fair value of working capital (including accounts receivable, inventory, accrued expenses, and accounts payables). Due to the short-term nature of the working capital, book value has been determined to be fair value. These accounts represent either avoided future outflows (inventory, prepaids) or future cash flows (accrued expense, AP and AR) related to customer sales.

Fair value of five years of revenue (2019 to 2023): we discounted our cash flows to the anticipated cash projected to be received. We also projected the anticipated cash outflows required to service these customers. If the asset group was to be valued as a whole, we would expect an income approach based on the revenues being generated from the customers and expenses required to service those customers, appropriately adjusted for the working capital position. The sum of these values reasonably approximates this approach.

-8-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

The Company’s revenue streams align directly with the intangibles, which were recorded as a result of the BergaMet acquisition in fiscal 2019. For purposes of the Step 2 recoverability test under ASC 360 subsection 2.3., the net revenues from BergaMet customers base were used. The revenue stream fairly reflects anticipated future cash flows; accordingly, the intangibles associated with these revenue streams have been tested with the expected cash flows.

Due to the purchase of Ultimate Brian Nutrients, LLC being a related party transaction and the new division recording no revenue as of June 30, 2020, the Company found the goodwill to be impaired. Due to the impairment the Company expensed the goodwill related to the purchase as of June 30, 2020.

Revenue Recognition

Beginning January 1, 2019, the Company implemented ASC 606, Revenue from Contracts with Customers. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures

The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

The Company records revenue upon shipment of the products to the customers.

Concentration

There is no concentration of revenue for the months ended June 30, 2019 and the months ended June 30, 2020 because the revenue was earned from multiple customers.

Income Taxes

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Accounting for Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. For the period ending December 31, 2019 and June 30, 2020, the Company did not have any amounts recorded pertaining to uncertain tax positions.

-9-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Fair Value Measurements

The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

The estimated fair value of certain financial instruments, including cash and cash equivalents are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

The derivative liability in connection with the conversion feature of the convertible debt, classified as a Level 3 liability, is the only financial liability measure at fair value on a recurring basis.

The change in Level 3 financial instrument is as follows:

Balance, January 1, 2020	$	1,060,388
Issued during the months ended June 30, 2020		1,668,799
Change in fair value recognized in operations		(593,602	)
Converted during the months ended June 30, 2020		(217,862	)
Balance, June 30, 2020	$	1,917,723

-10-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 amends the guidance for revenue recognition to replace numerous, industry specific requirements and converges areas under this topic with those of the International Financial Reporting Standards. The ASU implements of five–step process for customer contract revenue recognition that focuses on transfer of control, as opposed to transfer of risk and rewards. The amendment also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. Other major provisions include the capitalization and amortization of certain contract cost, ensuring the time value of money is considered in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The amendments in this ASU are effective for reporting period beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption.

The Company’s revenues are recognized when control of the promised goods or services is transferred to our clients (upon shipment of goods) in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: (1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the Company satisfies a performance obligation.

We adopted ASC 2014-09 on January 1, 2019. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities with them.

Convertible Instruments

The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

-11-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. During the months ended March 31, 2020, the Company did not have any conversions of convertible debt with a bifurcated conversion option.

Common Stock Purchase Warrants

The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC 815-40 ("Contracts in Entity's Own Equity"). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification is required.

Gain on Extinguishment of debt

Note Satisfaction Agreements

Prior to the Exchange, the Company entered into a Note Satisfaction Agreement with each of Auctus Fund, Crown Bridge Partners, LLC, Power Up Lending Group Ltd., GS Capital Partners LLC, Oakmore Opportunity Fund I LP, and Adar Bays, LLC. All of these entities were holders of the Company’s convertible debt, and these Note Satisfaction Agreements terminate their convertible notes unless the Company fails to perform its payment obligations. The Company agreed to pay these note holders an aggregate of $520,658 plus interest. The Company paid an aggregate of $353,908 on or before February 15, 2019. The balance owed and outstanding of $160,000 plus interest has not been paid and the two remaining notes are currently in default.

Various other holders of Convertible Promissory Notes agreed to convert their notes for an aggregate of 806,015 shares of common stock prior to the Exchange. As a result of these transactions, no convertible promissory notes remain outstanding, except for those convertible notes subject to revival if the Company fails to make payments pursuant to the Note Satisfaction Agreements.

NOTE 3 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated minimal revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring startup costs and expenses. As a result, the Company incurred accumulated net losses from Inception (December 19, 2014) through the period ended June 30, 2020 of $13,140,485. In addition, the Company’s development activities since inception have been financially sustained through equity financing. Management plans to seek funding through debt and equity financing and has recently acquired a new company as a wholly owned subsidiary.

-12-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 4 – RELATED PARTY

For the months ended June 30, 2020 and 2019, the Company had expenses totaling $80,000 and $24,000 respectively, to an officer and director for salaries, which is included in general and administrative expenses on the accompanying statement of operations As of June 30, 2020, there was a total of convertible debt of $1,050,866 and accrued interest payable of $480,217 due to an officer and director, employees, and shareholders.

NOTE 5 – CONVERTIBLE DEBT – RELATED PARTY

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 01/17/24, 4% interest, converts at $0.05 for a total of 30,604,333 shares			1,050,000
TOTAL		$	1,050,000

As of June 30, 2020, the Company has an outstanding total of $480,213 in accrued interest for the above convertible notes.

Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:

Payee	Number of options valued	Value of Convertible Option
Unsecured Convertible debt #1	30,604,333	$1,668,799

NOTE 6 – NOTES PAYABLE

As of June 30, 2020, the Company had the following:

Unsecured debt with shareholders of the Company, due 02/04/2020, 4% interest, interest due quarterly.		79,667
Unsecured debt with shareholders of the Company, no due date, 0% interest,		866

TOTAL	$	80,533

-13-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 6 – NOTES PAYABLE (CONTINUED)

As of June 30, 2020, the Company has an outstanding total of $4,479 in accrued interest for the above note and past obligations which are unpaid.

NOTE 7 – CONVERTIBLE DEBT

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 11/01/18, 12% interest, converts at a 50% discount to market price based on the last 25 days trading price		110,000
Unsecured convertible debt, due 02/02/19, 8% interest, converts at a 55% discount to market price based on the last 20 days trading price		50,000
Unsecured convertible debt, due 01/19/17, 8% interest, default interest at 18%, converts at a 54% discount to market price based on the lowest trading prices in the last 20 days trading price		6,750

SUBTOTAL		166,750
Less: Discount		—
TOTAL	$	166,750

Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:

Payee	Number of options valued	Value of Convertible Option
Unsecured Convertible debt #1	6,044,465	$181,531
Unsecured Convertible debt #2	2,136,272	$ 58,916
Unsecured Convertible debt #3	312,896	$ 8,477

-14-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 7 – CONVERTIBLE DEBT (CONTINUED)

As of June 30, 2020, the Company has an outstanding total of $55,976 in accrued interest for the above convertible notes.

Two of the convertible promissory notes feel into default during the first quarter of 2020, but we have been able to secure an extension for repayment on one of the two notes which will be August 1^st, 2020. We are in talks with the other party to extend the other note. With the note still being negotiated, we have calculated the derivative liability as if it is in default (but the note’s default interest rate stays the same at 8%) and will still accrue appropriate interest until the note is fully satisfied or converted into the Company’s common stock.

One of the convertible promissory notes is in default but management has not been able to make contact with this party, due to them living out of the country. We have calculated the derivative liability as if it is in default (but the note’s default interest rate stays the same at 8%) and will still accrue appropriate interest until the note is fully satisfied or converted into the Company’s common stock.

The Company has determined that the conversion feature embedded in the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt.

NOTE 8 – STOCKHOLDERS’ EQUITY

Authorized Stock

The Company has authorized 75,000,000 common shares with a par value of $0.001 per share. Each common share entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought. During February 2017, the Company increased the authorized number of shares to 500,000,000. Also, the Company increased the authorized preferred stock to 75,000,000 shares and designated 25,000,000 shares of preferred stock to Series A Convertible Preferred Stock. During January 2018, the Company increased its authorized number of common shares to 1,000,000,000. During April 2018, the Company increased its authorized number of common shares to 2,500,000,000. The Board of Directors, in the future, has the authority to increase the authorized capital up to 4,000,000,000 shares based on shareholder approval.

The shareholders of the Company approved a reverse stock split at a ratio of between 1-for-100 and 1-for 250. The Company received approval from FINRA for a reverse stock split of 1-for-250, which was effective as of July 23, 2018.

On October 16, 2017, the Company filed an Amended and Restated Certificate of Designation of the Rights, Preferences, Privileges and Restrictions of the Series A Convertible Preferred Stock (the “Amended Certificate”) with the Secretary of State of the State of Nevada. The Amended Certificate reduces the number of preferred shares designated as Series A Preferred Stock from 25,000,000 shares to 1,333,334 shares. The Amended Certificate also changes the conversion and voting rights of the Series A Preferred Stock. The Series A Preferred Stock is now convertible into the number of shares of our common stock equal to 0.00006% of our outstanding common stock upon conversion. The voting rights of the Series A Preferred Stock are now equal to the number of shares of common stock into which the Series A Preferred Stock may convert.

As of June 30, 2020, there are no outstanding shares of preferred stock. All the preferred stock was converted into common stock on February 4, 2019. See recent developments for details.

-15-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 8 – STOCKHOLDERS’ EQUITY (CONTINUED)

Common Share Issuances

During the months ended June 30, 2020, the Company issued 142,449,674 shares of common stock. 90,000,960 were issued for the purchase of Ultimate Brian Nutrients, LLC on April 3, 2020. On April 13, 2020, the Company issued 39,248,714 shares after coming to terms with the several of the convertible note holders. On June 17, 2020, the Company raised $660,000 in convertible notes and the note holders agreed to immediately convert the notes in to 13,200,000 shares.

Warrant Issuances

As of June 30, 2020, there were 16,800 warrants outstanding, of which 8,800 warrants are fully vested.

Stock Issued for Services

On January 28, 2019, the Company entered into a marketing and sales consulting agreement with an individual for a period of six months. The Company issued 350,000 shares of common stock as the compensation for this agreement.

Share Conversion Agreements

All of the holders of the Company’s Series A Convertible Preferred Stock (the “Preferred Holders”) entered into a Preferred Stock Conversion Agreement. Pursuant to the Conversion Agreements, the Preferred Holders converted their shares of preferred stock into common stock, effective as of the Exchange. As a result, no shares of the Company’s Series A Convertible Preferred Stock are outstanding. An aggregate of 15,592,986 shares of common stock were issued to the Preferred Holders. The Preferred Holders agreed to convert each share of Series A Convertible Preferred Stock into eighteen (18) shares of common stock and agreed to retire a total of 467,057 shares of Series A Convertible Preferred Stock. The Company cancelled the retired shares.

NOTE 9 – ACQUISITIONS

Acquisition of Ultimate Brain Nutrients, LLC

On April 3, 2020, the Company entered into a Share Exchange Agreement by and among Grey Cloak Tech Inc., Ultimate Brain Nutrients, LLC, a Delaware limited liability company (“UBN”), and the members of UBN, whereby we issued and exchanged 90,000,960 shares of our common stock for all of the outstanding equity securities of UBN. UBN is now our wholly-owned subsidiary. The shares of common stock issued in the Exchange are equal to approximately 42.5% of our outstanding common stock immediately following the exchange.

The assets acquired and liabilities assumed as part of our acquisition were recognized at their fair values as of the effective acquisition date, April 3, 2020. The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.

Cash	$	(5,466	)
Current assets		315,604
Current liabilities		0
Net assets acquired	$	310,137

-16-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 9 – ACQUISITIONS (CONTINUED)

The purchase price method was used when calculating the fair market value of the UBN purchase. On April 3, 2020 the closing stock price for GRCK was $0.021. The total number of shares exchanged multiplied by the closing stock price equaled a purchase value of $1,890,020. The difference between the net assets acquired and the purchase value was recorded as $1,579,883 of goodwill for the purchase. Due to the goodwill impairment, the Company fully expensed the goodwill recorded in this transaction. The Company viewed UBN’s balance sheet as being fairly valued as of April 3, 2020 so no adjustment was needed under the purchase price method of valuation.

Acquisition of BergaMet and the Share Exchange Agreement

On February 4, 2019, the Company entered into a Share Exchange Agreement with BergaMet NA, LLC, a Delaware limited liability company (“BergaMet”), and the members of BergaMet, whereby the Company issued and exchanged 97,409,678 shares of its common stock for all of the outstanding equity securities of BergaMet (the “Exchange”). Through the Exchange, BergaMet became a wholly-owned subsidiary of the Company. The shares of common stock issued in the Exchange were equal to 80.1% of the Company’s outstanding common stock (post-exchange).

The assets acquired and liabilities assumed as part of our acquisition were recognized at their fair values as of the effective acquisition date, February 4, 2019. The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.

Cash	$	437,826
Current assets		2,801,317
Current liabilities		(1,484,210	)
Net assets acquired	$	1,754,934

The purchase price method was used when calculating the fair market value of the BergaMet purchase. On February 4, 2019 the closing stock price for GRCK was $0.02. The total number of shares exchanged multiplied by the closing stock price equaled a purchase value of $1,948,194. The difference between the net assets acquired and the purchase value was recorded as $193,260 of goodwill for the purchase. The Company viewed BergaMet’s balance sheet as being fairly valued as of February 4, 2019 so no adjustment was needed under the purchase price method of valuation.

NOTE 10 – DISCONTINUED OPERATIONS

Healthy Extracts

On January 1, 2019, the Company decided to discontinue operating the Healthy Extracts division and did not operate it in 2019. At the time of the closure, the Company incurred a loss for the year of $714 which eliminated all carrying values of assets and liabilities for the division.

Eqova Life Science

On June 1, 2019, the Company decided to discontinue operating the Eqova Life Science division which ceased all activities in May 2019. Due to the closure, the Company incurred a loss for the year of $92,609 which eliminated all carrying values of assets and liabilities for the division.

-17-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 11 – BUSINESS SEGMENT INFORMATION

As of June 30, 2020, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the months ended June 30, 2020.

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		607,558			607,558			—			—
Cost of Revenue		216,646			216,646			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(2,760,363	)		(175,950	)		(77,341	)		(2,507,072	)
Identifiable Assets		3,072,356			3,072,356			—			—
Depreciation and Amortization		4,623			4,425			—			198

The following table presents selected financial information about the Company’s reportable segments for the three months ended June 30, 2020.

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		151.719			151,719			—			—
Cost of Revenue		20,589			20,589			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(3,385,173	)		(220,206	)		(77,341	)		(3,087,626	)
Identifiable Assets		3,072,356			3,072,356			—			0
Depreciation and Amortization		2,312			2,213			—			99

-18-

Table of Contents

GREY CLOAK TECH INC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2020 and 2019

NOTE 12 – SUBSEQUENT EVENTS

On May 30, 2020, the Company proposed a stock options agreement in the amount of 10,550,000 shares with a strike price of $0.05 to sixteen individuals.

During August 2020, two of the Company issued convertible debt notes were purchased by third parties totaling $160,000 in company convertible debt. The parties whom purchased these notes came to terms with the Company on the total debt and interest outstanding and agreed to convert those notes to shares in the third quarter of 2020. The total of $213,874 of debt and accrued interest was satisfied with the conversion to 3,400,000 shares.

On August 25, 2020, the Company came to agreement with two of the convertible debt note holders to execute the conversion of the note to shares. The amount converted was $1,129,667 in principal and $491,716 in accrued interest for 32,427,651 shares.

COVID-19

The COVID-19 outbreak in early 2020 has adversely affected, and may continue to adversely affect economic activity globally, nationally and locally. These economic and market conditions and other effects of the COVID-19 outbreak may adversely affect the Company. At this point, the extent to which COVID-19 may impact the Company's business is uncertain.

-19-

Table of Contents

ITEM 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our ability to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission.

Although the forward-looking statements in this Quarterly Statement reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

The following discussion and analysis of financial condition and results of operations of the Company is based upon, and should be read in conjunction with, its unaudited financial statements and related notes elsewhere in this Form 10-Q, which have been prepared in accordance with accounting principles generally accepted in the United States.

Summary Overview

We were formed in December 2014. We had revenues of $748,377 in the year ended December 31, 2019, $455,839 in the three months ended March 31, 2020, and $607,558 in the six months ended June 30, 2020.

Eqova Life Sciences

On October 17, 2017, we acquired Eqova Life Sciences, a Nevada corporation, through an exchange of shares of our Series A Convertible Preferred Stock for all of the outstanding equity interest of Eqova. As part of the Exchange, we brought on Eqova’s President and Director, Patrick Stiles, to serve as our President and Chief Executive Officer and as a Director on our Board of Directors. Mr. Stiles resigned in September 2018.

Eqova is a medically-focused CBD company that develops clinical grade full spectrum hemp oil products, sold exclusively via partnerships with licensed medical practitioners to use with their patients.

-20-

Table of Contents

We believed that Eqova provided us with a prime growth opportunity with an established business. Revenues of our hemp oil products from the acquisition of Eqova for the year ended December 31, 2018 were $64,384, but were $0 in 2019. We closed this business in the second quarter of 2019.

BergaMet NA, LLC

On February 4, 2019, we issued and exchanged shares of our common stock for all of the outstanding equity securities of BergaMet. The shares of common stock issued in the Exchange were equal to approximately 80.1% of our outstanding common stock immediately following the exchange.

Through the exchange, we were able to secure funds in BergaMet to pay off some debt and provide capital for operations. We paid an aggregate of $353,908 and were obligated to pay another $164,578 approximately one (1) year later to retire convertible debt. In the third quarter of 2020, we facilitated the sale of the then-outstanding debt to a third-party who converted it into an aggregate of 3,400,000 shares of our common stock. Prior to the exchange, we also entered into agreements with other holders of convertible debt to convert their notes for an aggregate of 806,015 shares of common stock. We also entered into conversion agreements with the holders of our Series A Convertible Preferred Stock whereby all of the outstanding preferred stock was converted for an aggregate of 15,592,986 shares of common stock. The conversion and repayment of the preferred stock and convertible debt have greatly improved our capitalization structure, as we now have no outstanding variable-price convertible debt.

The acquisition of BergaMet has been extremely beneficial to us. In addition to paying off our convertible debt, we are now able to better position ourselves in the market. BergaMet is an established company that was already generating revenues when we acquired it. BergaMet also has unique products that will fit nicely with our existing business. We now plan on expanding our product line to other nutraceuticals.

Ultimate Brain Nutrients, LLC

On April 3, 2020, we entered into a Share Exchange Agreement with Ultimate Brain Nutrients, LLC, a Delaware limited liability company (“UBN”), and the members of UBN, whereby we issued and exchanged 90,000,960 shares of our common stock for all of the outstanding equity securities of UBN. UBN is now our wholly-owned subsidiary. The shares of common stock issued in the Exchange were equal to approximately 42.5% of our outstanding common stock immediately following the exchange.

UBN is a science-based company that develops unique, plant-based superior health technology neuro-products that provide natural brain solutions. UBN has numerous proprietary products, with four unique patent-pending formulations and one patent issued.

Financial results for UBN are not included in this Management’s Discussion and Analysis because it was acquired after the three months ended March 31, 2020.

Going Concern

As a result of our financial condition, we have received a report from our independent registered public accounting firm for our financial statements for the years ended December 31, 2019 and 2018 that includes an explanatory paragraph describing the uncertainty as to our ability to continue as a going concern. From inception (December 19, 2014) through the end of June 30, 2020, we have incurred accumulated net losses of $ $13,140,485.. In order to continue as a going concern we must effectively balance many factors and generate more revenue so that we can fund our operations from our sales and revenues. If we are not able to do this we may not be able to continue as an operating company. At our current revenue and burn rate, our cash on hand will last less than one month, and thus we must raise capital by issuing debt or through the sale of our stock. However, there is no assurance that our existing cash flow will be adequate to satisfy our existing operating expenses and capital requirements.

-21-

Table of Contents

Results of Operations for the Three and Six Months Ended June 30, 2020 and 2019

Introduction

We had revenues of $151,719 and $607,558 for the three and six months ended June 30, 2020, compared to $201,040 and $298,313 for the three and six months ended June 30, 2019. Revenues for the three months ended March 31, 2020 were $455,839. Our revenues for the three months ended June 30, 2020 were 66% lower than the immediately preceding quarter.

Our operating expenses were $444,318 and $651,950 for the three and six months ended June 30, 2020, compared to $300,109 and $562,625 for the three and six months ended June 30, 2019. Operating expenses for the three months ended March 31, 2020 were $207,632. Our operating expenses were 53% higher than the immediately preceding quarter.

Our operating expenses consisted entirely of general and administrative expenses.

Revenues and Net Operating Loss

Our revenue, operating expenses, net operating loss, and net gain (loss) for the three and six months ended June 30, 2020 and 2019 were as follows:

	Three Months Ended						Six Months Ended
	June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019

Revenue	$	151,719		$	201,040		$	607,558		$	298,313

Cost of Revenue		20,589			46,241			216,646			78,004

Gross Profit		131,130			154,799			390,912			220,308

Operating expenses:
General and administrative		444,318			300,109			651,950			562,625
Total operating expenses		444,318			300,109			651,950			562,625

Other income (expense)
Interest expenses, net of interest income		(19,631	)		(19,675	)		(62,107	)		(32,539	)
Change in fair value on derivative		(1,472,471	)		(113,407	)		(857,335	)		1,636,029
Loss on extinguishment of debt		—			—			—			53,038
Impairment of Assets		(1,579,883	)		—			(1,579,883	)		—
Gain on sale of asset		—			—			—			—
Total other income (expense)		(3,071,985	)		(133,082	)		2,499,325			1,656,528

Net income (loss)	$	(3,385,173	)	$	(278,392	)	$	(2,760,363	)	$	1,314,212

-22-

Table of Contents

Revenues

Revenues were $151,719 and $607,658 for the three and six months ended June 30, 2020, compared to $201,040 and $298,313 for the three and six months ended June 30, 2019, a decrease of 25% for the three month periods and an increase of 104% for the six month periods. The increase for the six month periods supports the transition to our new business selling health nutrition products.

Cost of Revenue

Cost of revenue was $20,589 and $216,646 for the three and six months ended June 30, 2020, compared to $46,241 and $78,004 for the three and six months ended June 30, 2019, a decrease of 55% for the three month periods and an increase of 177% for the six month periods. Gross profit was $131,130 and $390,912 for the three and six months ended June 30, 2020, compared to $154,799 and $220,308 for the three and six months ended June 30, 2019, a decrease of 15% for the three month periods and an increase of 77% for the six month periods.

Cost of revenue as a percentage of revenues was 14% for the three months ended June 30, 2020, compared to 36% for the six months ended June 30, 2020.

General and Administrative

General and administrative expenses were $444,318 and $651,950 for the three and six months ended June 30, 2020, compared to $300,109 and $562,625 for the three and six months ended June 30, 2019. In the three months ended June 30, 2020, general and administrative expenses consisted mainly of professional fees of $73,058, consulting fees of $201,445, salary and wages of $38,381, postage of $10,202, advertising of $68,635, and transfer agent and filing fees of $13,860. In the three months ended June 30, 2019, general and administrative expenses consisted mainly of professional fees of $26,095, consulting fees of $126,916, salary and wages of $37,272, postage of $12,608, advertising of $36,389, and transfer agent and filing fees of $2,122.

Other Income (Expense)

Other income (expense) was $(3,071,985) and $(2,499,325) for the three and six months ended June 30, 2020, compared to $(133,082) and $1,656,528 for the three and six months ended June 30, 2019, an increase of over 2,400% for the three month periods and 51% for the six month periods. In the three months ended June 30, 2020, other income (expense) consisted of interest expense, net of interest income of $(19,631), change in fair value on derivative of $1,472,471, and impairment of assets of $1,579,883. Impairment of assets was related to the UBN purchase and was the difference between the net assets acquired and the purchase value of $1,579,883. Due to the goodwill impairment, we fully expensed the goodwill recorded in this transaction. In the three months ended June 30, 2019, other income (expense) consisted of interest expense, net of interest income of $(19,675), and change in fair value on derivative of $(113,407).

Net Income (Loss)

Net income (loss) was $(3,385,173) and $(2,760,363), or $(0.02) and $(0.01) per share, for the three and six months ended June 30, 2020, compared to $(278,392) and $1,314,212, or $0 and $0.01 per share, for the three and six months ended June 30, 2019.

Our net loss increased in 2020 primarily because of a change in fair value on derivative and impairment of the UBN assets.

-23-

Table of Contents

Liquidity and Capital Resources

Introduction

During the three months ended June 30, 2020, we were unable to generate sufficient revenues and had negative operating cash flows. Our cash on hand as of December 31, 2019 was $133,451, and as of June 30, 2020 was $664,156. The increase in cash on hand was primarily from our net cash used in operating activities of $(1,844,956), offset by net cash provided by financing activities of $2,712,552. Our monthly cash flow burn rate for 2019 (not including inventory purchases) was approximately $46,000, and for the six months ended June 30, 2020 it was approximately $307,000. We have strong short and medium term cash needs. We anticipate that these needs will be satisfied through increased revenues and the issuance of debt or the sale of our securities until such time as our cash flows from operations will satisfy our cash flow needs.

Our cash, current assets, total assets, current liabilities, and total liabilities as of June 30, 2020 and December 31, 2019, respectively, are as follows:

	June 30,		December 31,		Increase/
	2020		2019		(Decrease)

Cash	$	664,156	$	133,451	$	530,705
Total Current Assets		3,741,814		3,241,083		500,731
Total Assets		4,282,525		3,449,526		832,999
Total Current and Total Liabilities		3,854,070		4,315,136	$	(461,066.00	)

Our total current assets and total assets increased primarily as a result of our increase in cash of $530,705 and our increase in patents and trademarks from the UBN acquisition. Our total current and total liabilities decreased by $461,066 during the six months ended June 30, 2020 primarily because of a reduction in convertible debt – related party of $1,341,876, offset in part by an increase in derivative liabilities of $857,335. Our accumulated deficit increased during the six months ended June 30, 2020 by $2,760,363 to $13,140,485.

In order to repay our obligations in full or in part when due, we will be required to raise significant capital from other sources. There is no assurance, however, that we will be successful in these efforts.

Cash Requirements

Our cash on hand as of June 30, 2020 was $664,156. Based on our current level of revenues and monthly burn rate of approximately $307,000 per month, we will need to continue to fund operations by raising capital from the sale of our stock and debt financings.

Sources and Uses of Cash

Operating Activities

We had net cash used in operating activities of $1,844,956 for the six months ended June 30, 2020, compared to $2,176,435 for the six months ended June 30, 2019. We use our cash for normal business operations. Our net cash used in operating activities consisted of our net loss of $2,760,363, offset in part by a change in fair value on derivative liability of $857,335.

-24-

Table of Contents

Investing Activities

We had $(336,891) in cash flows provided by investing activities for the six months ended June 30, 2020, compared to $3,870,331 for the six months ended June 30, 2019.

Financing Activities

Our net cash provided by financing activities for the six months ended June 30, 2020 was $2,712,552, compared to $552,278 for the six months ended June 30, 2019. Our net cash provided by financing activities consisted of proceeds from the issuance of common stock of $4,054,428, offset by proceeds from the issuance of convertible debt of $(1,341,876).

ITEM 3

Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 4

Controls and Procedures

(a) Disclosure Controls and Procedures

We conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, as of June 30, 2020, to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities Exchange Commission’s rules and forms, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2020, our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses identified and described in our Annual Report on Internal Control Over Financial Reporting filed in our Annual Report on Form 10-K.

Our principal executive officers do not expect that our disclosure controls or internal controls will prevent all errors and all fraud. Although our disclosure controls and procedures were designed to provide reasonable assurance of achieving their objectives and our principal executive officers have determined that our disclosure controls and procedures are effective at doing so, a control system, no matter how well conceived and operated, can provide only reasonable, not absolute assurance that the objectives of the system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented if there exists in an individual a desire to do so. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

(b) Changes in Internal Control over Financial Reporting

No change in our system of internal control over financial reporting occurred during the period covered by this report, the three month period ended June 30, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

-25-

Table of Contents

PART II – OTHER INFORMATION

ITEM 1

Legal Proceedings

We are not a party to or otherwise involved in any legal proceedings.

In the ordinary course of business, we are from time to time involved in various pending or threatened legal actions. The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations. However, in the opinion of our management, other than as set forth herein, matters currently pending or threatened against us are not expected to have a material adverse effect on our financial position or results of operations.

ITEM 1A

Risk Factors

As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 2

Unregistered Sales of Equity Securities and Use of Proceeds

Note Conversion Agreements and Advance Conversion Agreements

Effective April 13, 2020, we entered into a total of eighteen (18) agreements (16 Note Conversion Agreements and 2 Advance Conversion Agreements) whereby an aggregate of $1,508,407.84 in outstanding principal and accrued interest was converted into an aggregate of 39,248,714 shares of our common stock. The conversion price was either $0.03 per share or $0.05 per share, depending on the individual agreement. The conversions included notes and advances held by our officers and directors and our largest shareholder, as follows:

Name	Aggregate Principal and Interest		Aggregate Shares
Jay W. Decker	$	1,282,231.11		33,418,004
William Bossung	$	65,677.84		2,189,262
First Capital Properties LLC	$	16,180.00		539,334
Shelton S. Decker	$	33,717.78		782,223
Logan B. Decker	$	33,717.78		782,223
Kevin Pitts	$	51,255.56		1,025,112
Innovation Group Holdings, LLC	$	25,627.78		512,556

The shares of common stock issued pursuant to the Note Conversion Agreements and the Advance Conversion Agreements were offered and sold in reliance on an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. The investors have acquired the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof. The securities were not issued through any general solicitation or advertisement.

-26-

Table of Contents

ITEM 3

Defaults Upon Senior Securities

There have been no events which are required to be reported under this Item.

ITEM 4

Mine Safety Disclosures

Not applicable.

ITEM 5

Other Information

None.

ITEM 6

Exhibits

(a) Exhibits

Exhibit Number		Name and/or Identification of Exhibit

10.1 (1)		Share Exchange Agreement with Ultimate Brain Nutrients, LLC and its members

31.1		Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

31.2		Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

32.1		Chief Executive Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Chief Financial Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

100.INS		XBRL Instance Document

100.SCH		XBRL Schema Document

100.CAL		XBRL Calculation Linkbase Document

100.DEF		XBRL Definition Linkbase Document

100.LAB		XBRL Labels Linkbase Document

100.PRE		XBRL Presentation Linkbase Document

(1) Incorporated by reference from our Current Report on Form 8-K filed with the Commission on April 8, 2020.

-27-

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Grey Cloak Tech Inc.


Dated: September 15, 2020	/s/ Kevin Pitts
	By: Kevin “Duke” Pitts
	Its: President

-28-

EX-31.1 2 grck-20200630_10qex31z1.htm EX-31.1

EXHIBIT 31.1

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

I, Kevin “Duke” Pitts, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Grey Cloak Tech Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exhibit Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: September 15, 2020
		/s/ Kevin Pitts
	By:	Kevin “Duke” Pitts
		President

EX-31.2 3 grck-20200630_10qex31z2.htm EX-31.2

EXHIBIT 31.2

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

I, William Bossung, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Grey Cloak Tech Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: September 15, 2020
		/s/ William Bossung
	By	William Bossung
		Chief Financial Officer

EX-32.1 4 grck-20200630_10qex32z1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Grey Cloak Tech Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Kevin “Duke” Pitts, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 15, 2020
		/s/ Kevin Pitts
	By:	Kevin “Duke” Pitts
		President

A signed original of this written statement required by Section 906 has been provided to Grey Cloak Tech Inc., and will be retained by Grey Cloak Tech Inc., and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 grck-20200630_10qex32z2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Grey Cloak Tech Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, William Bossung, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 15, 2020
		/s/ William Bossung
	By:	William Bossung
		Chief Financial Officer

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.INS 7 grck-20200630.xml XBRL INSTANCE FILE 0001630176 2020-01-01 2020-06-30 0001630176 2019-12-31 0001630176 2020-06-30 0001630176 grck:OfficeAndDirectorMember 2020-01-01 2020-06-30 0001630176 2020-09-14 0001630176 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:LiabilityMember 2019-12-31 0001630176 grck:OfficeAndDirectorMember 2019-01-01 2019-06-30 0001630176 grck:UnsecuredConvertibleDebt4Member 2020-01-01 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt5Member 2020-01-01 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt6Member 2020-01-01 2020-06-30 0001630176 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001630176 us-gaap:CorporateMember 2020-01-01 2020-06-30 0001630176 grck:BergaMetMember 2019-02-04 0001630176 us-gaap:PreferredStockMember 2020-01-01 2020-06-30 0001630176 us-gaap:PreferredStockMember 2019-12-31 0001630176 us-gaap:PreferredStockMember 2020-06-30 0001630176 us-gaap:CommonStockMember 2019-12-31 0001630176 us-gaap:CommonStockMember 2020-06-30 0001630176 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001630176 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001630176 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001630176 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001630176 us-gaap:RetainedEarningsMember 2019-12-31 0001630176 us-gaap:RetainedEarningsMember 2020-06-30 0001630176 2019-01-01 2019-06-30 0001630176 2019-06-30 0001630176 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:LiabilityMember 2020-01-01 2020-06-30 0001630176 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:LiabilityMember 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt8Member 2020-01-01 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt9Member 2020-06-30 0001630176 2018-12-31 0001630176 us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001630176 us-gaap:PreferredStockMember 2018-12-31 0001630176 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001630176 us-gaap:CommonStockMember 2018-12-31 0001630176 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001630176 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001630176 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001630176 us-gaap:RetainedEarningsMember 2018-12-31 0001630176 2019-01-01 2019-12-31 0001630176 grck:OfficeAndDirectorMember 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt8Member 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt4Member 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt5Member 2020-06-30 0001630176 grck:UnsecuredConvertibleDebt6Member 2020-06-30 0001630176 grck:HealthyExtractsMember 2020-01-01 2020-06-30 0001630176 grck:EqovaLifeScienceMember 2020-01-01 2020-06-30 0001630176 2020-04-01 2020-06-30 0001630176 2019-04-01 2019-06-30 0001630176 grck:BergaMetMember 2020-01-01 2020-06-30 0001630176 grck:UltimateBrainNutrientsLLCMember 2020-01-01 2020-06-30 0001630176 grck:UnsecuredConvertibleDebtDue011724Member 2020-01-01 2020-06-30 0001630176 grck:UnsecuredConvertibleDebtDue011724Member 2020-06-30 0001630176 grck:UltimateBrainNutrientsLLCMember 2020-04-03 0001630176 grck:HealthSupplementsMember grck:BergaMetMember 2020-01-01 2020-06-30 0001630176 grck:HealthSupplementsMember grck:BergaMetMember 2020-04-01 2020-06-30 0001630176 grck:HealthSupplementsMember grck:UltimateBrainNutrientsLLCMember 2020-01-01 2020-06-30 0001630176 grck:HealthSupplementsMember grck:UltimateBrainNutrientsLLCMember 2020-04-01 2020-06-30 0001630176 grck:HealthSupplementsMember grck:UltimateBrainNutrientsLLCMember 2020-06-30 0001630176 grck:HealthSupplementsMember grck:BergaMetMember 2020-06-30 0001630176 us-gaap:CorporateMember 2020-04-01 2020-06-30 0001630176 us-gaap:CorporateMember 2020-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure GREY CLOAK TECH INC. 0001630176 10-Q 2020-06-30 false --12-31 No Non-accelerated Filer Q2 2020

3449526

4282525

-865610

428456

121610

264060

9392903

13304881

-10380123

-13140485

-3564216

1333

6455

7440895

-11012899

-10380123

-13140485

9392903

13304881

121610

264060

4315136

3854070

4315136

3854070

21125

44270

3449526

4282525

208443

540711

15183

10560

3241083

3741814

26473

15862

133451

664156

2246660

485

36895

39207

0.001

2500000000

121610085

264059759

121610085

264059759

216646

78004

20589

46241

216646

20589

651950

562625

444318

300109

651950

562625

444318

300109

-62107

-32539

-19631

-19675

-2499325

1656528

-3071985

-133082

-2760363

1314212

632776

-3385173

-278392

-0.01

0.01

-0.02

223697036

110612376

182890767

98883192

4623

198

1614

2312

4425

2213

10611

-27157

23145

-11240

781

-1844956

-2176435

-336891

3870331

2712552

552278

530705

2246175

299887410

1050866

166750

49902

60455

491221 480217 480217

1060388

1917723

1060388

1917723

53038

-857335

1636029

-1472471

-113407

-1341876

-71092

79295

-11004

769

10553

393558

-15000

349330

0.001

75000000

97409678

90000960

4762

3081158

3061796

193260

1341876 1050866 1050000

390912

220308

131130

154799

19362

-2343328

607558

298313

151719

201040

607558

151719

-15000

true true false

79667

-63000 false

7000

Yes NV 000-55572 1050700

1907010

108260

53341

54122

22985

The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%"> Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">437,826</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,801,317</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Current liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,484,210</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,754,934</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(5,466</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">315,604</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Current liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">310,137</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

1668799 -593602 -217862

80000

24000

0.04

0.12

0.08

0.04

2018-11-01

2019-02-02

2017-01-19

2020-02-04

2024-01-17

0.50

0.55

0.18

866

79667

166750

110000

50000

6750

437826

-5466

2801317

315604

1484210

1754934

310137

193260

336891

530151

-2760363

-2507072

1314212

-3385173

-278392

-175950

-220206

-77341

-3087626

3072356 3072356 3072356 3072356 0

714

92609

857335

-1941315

true 336891

1579883

4054428

-336891 1907010

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS   Grey Cloak Tech Inc. (the “Company”) was incorporated in the State of Nevada on December 19, 2014. The Company has additionally acquired BergaMet NA, LLC which markets and sells heath supplemental products, and Ultimate Brain Nutrients, LLC which develops plant-based neuro-products that provide natural brain solutions.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation   The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020 and the results of operations and cash flows for the periods presented. The results of operations for the six months ended June 30, 2020 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s form 10-K for the year ended December 31, 2019 filed with the SEC on August 10, 2020.   Use of Estimates   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.  Actual results could differ from those estimates.   Cash   Cash includes cash in banks, money market funds, and certificates of term deposits with maturities of less than three months from inception, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value.   Accounts Receivables   Accounts receivables are recorded at the invoice amount and do not bear interest.   Inventory   Inventories consist of health supplements held for sale in the ordinary course of business. The Company uses the weighted average cost method to value its inventories at the lower of cost or market. An allowance for inventory was established in 2018 and is evaluated each quarter to determine if all items are still sellable due to expiration dates. As of June 30, 2020 and 2019, the total of inventory which was written off as an inventory allowance was $748,972 and $324,014.   Property and Equipment   The Company’s property and equipment are recorded at cost and depreciated using the straight-line method over the useful lives of the assets, generally from three to seven years. Upon sale or disposal of property and equipment, the related asset cost and accumulated depreciation or amortization are removed from the respective accounts and any gain or loss is reflected in current operations.   Goodwill   In accordance with Goodwill and Other Intangible Assets, goodwill is defined as the excess of the purchase price over the fair value assigned to individual assets acquired and liabilities assumed and is tested for impairment at the reporting unit level on an annual basis in the Company's fourth fiscal quarter or more frequently if indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair value of the Company's reporting units with each respective reporting unit's carrying amount, including goodwill. The fair value of reporting units is generally determined using the income approach. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the second step of the goodwill impairment test is performed to determine the amount of any impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. The Company sees the goodwill to have a ten-year useful life. No goodwill impairment indicators were present, for the goodwill listed on the books as of March 31, 2020, after working through our analysis of goodwill during the months ending June 30, 2020.   The Company has determined that the method applied represents the fair value of the asset group principally because the valuation of the intangibles with the asset group is based on the anticipated cash flows related to the revenue stream from its customers. The asset group excludes goodwill, long term non-operational assets and liabilities and cash. As such, the principal value from the asset group relates to the cash inflows from its customers and the cash outflows required to service these customers. The fair value for the asset group consists of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of net revenues: computed using the income approach. The key input to these computations is the anticipated cash inflows from customers. These valuations include 100% of the cash inflows related to the customer base, and taking cash outflows into consideration.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of working capital (including accounts receivable, inventory, accrued expenses, and accounts payables). Due to the short-term nature of the working capital, book value has been determined to be fair value. These accounts represent either avoided future outflows (inventory, prepaids) or future cash flows (accrued expense, AP and AR) related to customer sales.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of five years of revenue (2019 to 2023): we discounted our cash flows to the anticipated cash projected to be received. We also projected the anticipated cash outflows required to service these customers. If the asset group was to be valued as a whole, we would expect an income approach based on the revenues being generated from the customers and expenses required to service those customers, appropriately adjusted for the working capital position. The sum of these values reasonably approximates this approach.</td></tr> </table>   The Company’s revenue streams align directly with the intangibles, which were recorded as a result of the BergaMet acquisition in fiscal 2019. For purposes of the Step 2 recoverability test under ASC 360 subsection 2.3., the net revenues from BergaMet customers base were used. The revenue stream fairly reflects anticipated future cash flows; accordingly, the intangibles associated with these revenue streams have been tested with the expected cash flows.   Due to the purchase of Ultimate Brian Nutrients, LLC being a related party transaction and the new division recording no revenue as of June 30, 2020, the Company found the goodwill to be impaired. Due to the impairment the Company expensed the goodwill related to the purchase as of June 30, 2020.   Revenue Recognition   Beginning January 1, 2019, the Company implemented ASC 606, Revenue from Contracts with Customers.  Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them.  These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures   The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services.  To achieve this core principle, we apply the following five steps:  identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.   The Company records revenue upon shipment of the products to the customers.   Concentration   There is no concentration of revenue for the months ended June 30, 2019 and the months ended June 30, 2020 because the revenue was earned from multiple customers.   Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Accounting for Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. For the period ending December 31, 2019 and June 30, 2020, the Company did not have any amounts recorded pertaining to uncertain tax positions.   Fair Value Measurements   The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.   The estimated fair value of certain financial instruments, including cash and cash equivalents are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.   ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:   Level 1 — quoted prices in active markets for identical assets or liabilities   Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable   Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)   The derivative liability in connection with the conversion feature of the convertible debt, classified as a Level 3 liability, is the only financial liability measure at fair value on a recurring basis.   The change in Level 3 financial instrument is as follows:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; padding-left: 5.4pt">Balance, January 1, 2020</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,060,388</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Issued during the months ended June 30, 2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,668,799</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Change in fair value recognized in operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(593,602</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Converted during the months ended June 30, 2020</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(217,862</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance, June 30, 2020</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,917,723</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Recent Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 amends the guidance for revenue recognition to replace numerous, industry specific requirements and converges areas under this topic with those of the International Financial Reporting Standards. The ASU implements of five–step process for customer contract revenue recognition that focuses on transfer of control, as opposed to transfer of risk and rewards. The amendment also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. Other major provisions include the capitalization and amortization of certain contract cost, ensuring the time value of money is considered in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The amendments in this ASU are effective for reporting period beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption.   The Company’s revenues are recognized when control of the promised goods or services is transferred to our clients (upon shipment of goods) in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: (1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the Company satisfies a performance obligation.   We adopted ASC 2014-09 on January 1, 2019. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities with them.   Convertible Instruments   The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.   Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.   The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.   The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. During the months ended March 31, 2020, the Company did not have any conversions of convertible debt with a bifurcated conversion option.   Common Stock Purchase Warrants   The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC 815-40 ("Contracts in Entity's Own Equity"). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification is required.   Gain on Extinguishment of debt   Note Satisfaction Agreements   Prior to the Exchange, the Company entered into a Note Satisfaction Agreement with each of Auctus Fund, Crown Bridge Partners, LLC, Power Up Lending Group Ltd., GS Capital Partners LLC, Oakmore Opportunity Fund I LP, and Adar Bays, LLC. All of these entities were holders of the Company’s convertible debt, and these Note Satisfaction Agreements terminate their convertible notes unless the Company fails to perform its payment obligations. The Company agreed to pay these note holders an aggregate of $520,658 plus interest. The Company paid an aggregate of $353,908 on or before February 15, 2019. The balance owed and outstanding of $160,000 plus interest has not been paid and the two remaining notes are currently in default.   Various other holders of Convertible Promissory Notes agreed to convert their notes for an aggregate of 806,015 shares of common stock prior to the Exchange. As a result of these transactions, no convertible promissory notes remain outstanding, except for those convertible notes subject to revival if the Company fails to make payments pursuant to the Note Satisfaction Agreements.

NOTE 3 – GOING CONCERN   The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated minimal revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring startup costs and expenses. As a result, the Company incurred accumulated net losses from Inception (December 19, 2014) through the period ended June 30, 2020 of $13,140,485. In addition, the Company’s development activities since inception have been financially sustained through equity financing. Management plans to seek funding through debt and equity financing and has recently acquired a new company as a wholly owned subsidiary.

NOTE 4 – RELATED PARTY   For the months ended June 30, 2020 and 2019, the Company had expenses totaling $80,000 and $24,000 respectively, to an officer and director for salaries, which is included in general and administrative expenses on the accompanying statement of operations As of June 30, 2020, there was a total of convertible debt of $1,050,866 and accrued interest payable of $480,217 due to an officer and director, employees, and shareholders.

NOTE 5 – CONVERTIBLE DEBT – RELATED PARTY   As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; width: 70%; text-align: justify; padding-left: 5.4pt">Unsecured convertible debt, due 01/17/24, 4% interest, converts at $0.05 for a total of 30,604,333 shares</td><td style="padding-bottom: 1pt; width: 10%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right">1,050,000</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,050,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   As of June 30, 2020, the Company has an outstanding total of $480,213 in accrued interest for the above convertible notes. Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Payee</td><td style="font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-weight: bold">Number of options valued</td><td style="font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-weight: bold">Value of Convertible Option</td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Unsecured Convertible debt #1</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 20%; text-align: center">30,604,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">1,668,799</td><td style="width: 1%; text-align: left"> </td></tr> </table> NOTE 6 – NOTES PAYABLE   As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; text-align: left; padding-left: 5.4pt">Unsecured debt with shareholders of the Company, due 02/04/2020, 4% interest, interest due quarterly.</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">79,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Unsecured debt with shareholders of the Company, no due date, 0% interest,</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">866</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">80,533</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   As of June 30, 2020, the Company has an outstanding total of $4,479 in accrued interest for the above note and past obligations which are unpaid.

NOTE 7 – CONVERTIBLE DEBT   As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 11/01/18, 12% interest, converts at a 50% discount to market price based on the last 25 days trading price</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">110,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 02/02/19, 8% interest, converts at a 55% discount to market price based on the last 20 days trading price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 01/19/17, 8% interest, default interest at 18%, converts at a 54% discount to market price based on the lowest trading prices in the last 20 days trading price</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">SUBTOTAL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Less: Discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">166,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Payee</td><td style="font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-weight: bold">Number of options valued</td><td style="font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-weight: bold">Value of Convertible Option</td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Unsecured Convertible debt #1</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 20%; text-align: center">6,044,465</td><td style="width: 1%; text-align: center"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">181,531</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Unsecured Convertible debt #2</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">2,136,272</td><td style="text-align: center"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">58,916</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Unsecured Convertible debt #3</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">312,896</td><td style="text-align: center"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,477</td><td style="text-align: left"> </td></tr> </table>   As of June 30, 2020, the Company has an outstanding total of $55,976 in accrued interest for the above convertible notes.   Two of the convertible promissory notes feel into default during the first quarter of 2020, but we have been able to secure an extension for repayment on one of the two notes which will be August 1st, 2020. We are in talks with the other party to extend the other note. With the note still being negotiated, we have calculated the derivative liability as if it is in default (but the note’s default interest rate stays the same at 8%) and will still accrue appropriate interest until the note is fully satisfied or converted into the Company’s common stock.   One of the convertible promissory notes is in default but management has not been able to make contact with this party, due to them living out of the country. We have calculated the derivative liability as if it is in default (but the note’s default interest rate stays the same at 8%) and will still accrue appropriate interest until the note is fully satisfied or converted into the Company’s common stock.   The Company has determined that the conversion feature embedded in the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt.

NOTE 8 – STOCKHOLDERS’ EQUITY   Authorized Stock    The Company has authorized 75,000,000 common shares with a par value of $0.001 per share.  Each common share entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought. During February 2017, the Company increased the authorized number of shares to 500,000,000. Also, the Company increased the authorized preferred stock to 75,000,000 shares and designated 25,000,000 shares of preferred stock to Series A Convertible Preferred Stock. During January 2018, the Company increased its authorized number of common shares to 1,000,000,000. During April 2018, the Company increased its authorized number of common shares to 2,500,000,000. The Board of Directors, in the future, has the authority to increase the authorized capital up to 4,000,000,000 shares based on shareholder approval.   The shareholders of the Company approved a reverse stock split at a ratio of between 1-for-100 and 1-for 250. The Company received approval from FINRA for a reverse stock split of 1-for-250, which was effective as of July 23, 2018.   On October 16, 2017, the Company filed an Amended and Restated Certificate of Designation of the Rights, Preferences, Privileges and Restrictions of the Series A Convertible Preferred Stock (the “Amended Certificate”) with the Secretary of State of the State of Nevada. The Amended Certificate reduces the number of preferred shares designated as Series A Preferred Stock from 25,000,000 shares to 1,333,334 shares. The Amended Certificate also changes the conversion and voting rights of the Series A Preferred Stock. The Series A Preferred Stock is now convertible into the number of shares of our common stock equal to 0.00006% of our outstanding common stock upon conversion. The voting rights of the Series A Preferred Stock are now equal to the number of shares of common stock into which the Series A Preferred Stock may convert.   As of June 30, 2020, there are no outstanding shares of preferred stock. All the preferred stock was converted into common stock on February 4, 2019. See recent developments for details.   Common Share Issuances   During the months ended June 30, 2020, the Company issued 142,449,674 shares of common stock. 90,000,960 were issued for the purchase of Ultimate Brian Nutrients, LLC on April 3, 2020. On April 13, 2020, the Company issued 39,248,714 shares after coming to terms with the several of the convertible note holders. On June 17, 2020, the Company raised $660,000 in convertible notes and the note holders agreed to immediately convert the notes in to 13,200,000 shares.   Warrant Issuances   As of June 30, 2020, there were 16,800 warrants outstanding, of which 8,800 warrants are fully vested.   Stock Issued for Services   On January 28, 2019, the Company entered into a marketing and sales consulting agreement with an individual for a period of six months. The Company issued 350,000 shares of common stock as the compensation for this agreement.   Share Conversion Agreements   All of the holders of the Company’s Series A Convertible Preferred Stock (the “Preferred Holders”) entered into a Preferred Stock Conversion Agreement. Pursuant to the Conversion Agreements, the Preferred Holders converted their shares of preferred stock into common stock, effective as of the Exchange. As a result, no shares of the Company’s Series A Convertible Preferred Stock are outstanding. An aggregate of 15,592,986 shares of common stock were issued to the Preferred Holders. The Preferred Holders agreed to convert each share of Series A Convertible Preferred Stock into eighteen (18) shares of common stock and agreed to retire a total of 467,057 shares of Series A Convertible Preferred Stock. The Company cancelled the retired shares.

NOTE 9 – ACQUISITIONS   Acquisition of Ultimate Brain Nutrients, LLC   On April 3, 2020, the Company entered into a Share Exchange Agreement by and among Grey Cloak Tech Inc., Ultimate Brain Nutrients, LLC, a Delaware limited liability company (“UBN”), and the members of UBN, whereby we issued and exchanged 90,000,960 shares of our common stock for all of the outstanding equity securities of UBN. UBN is now our wholly-owned subsidiary. The shares of common stock issued in the Exchange are equal to approximately 42.5% of our outstanding common stock immediately following the exchange.   The assets acquired and liabilities assumed as part of our acquisition were recognized at their fair values as of the effective acquisition date, April 3, 2020. The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(5,466</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">315,604</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Current liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">310,137</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   The purchase price method was used when calculating the fair market value of the UBN purchase. On April 3, 2020 the closing stock price for GRCK was $0.021. The total number of shares exchanged multiplied by the closing stock price equaled a purchase value of $1,890,020. The difference between the net assets acquired and the purchase value was recorded as $1,579,883 of goodwill for the purchase. Due to the goodwill impairment, the Company fully expensed the goodwill recorded in this transaction. The Company viewed UBN’s balance sheet as being fairly valued as of April 3, 2020 so no adjustment was needed under the purchase price method of valuation.   Acquisition of BergaMet and the Share Exchange Agreement   On February 4, 2019, the Company entered into a Share Exchange Agreement with BergaMet NA, LLC, a Delaware limited liability company (“BergaMet”), and the members of BergaMet, whereby the Company issued and exchanged 97,409,678 shares of its common stock for all of the outstanding equity securities of BergaMet (the “Exchange”). Through the Exchange, BergaMet became a wholly-owned subsidiary of the Company. The shares of common stock issued in the Exchange were equal to 80.1% of the Company’s outstanding common stock (post-exchange).   The assets acquired and liabilities assumed as part of our acquisition were recognized at their fair values as of the effective acquisition date, February 4, 2019. The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%"> Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">437,826</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,801,317</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left">Current liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,484,210</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,754,934</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   The purchase price method was used when calculating the fair market value of the BergaMet purchase. On February 4, 2019 the closing stock price for GRCK was $0.02. The total number of shares exchanged multiplied by the closing stock price equaled a purchase value of $1,948,194. The difference between the net assets acquired and the purchase value was recorded as $193,260 of goodwill for the purchase. The Company viewed BergaMet’s balance sheet as being fairly valued as of February 4, 2019 so no adjustment was needed under the purchase price method of valuation.

NOTE 10 – DISCOUNTINUED OPERATIONS   Healthy Extracts   On January 1, 2019, the Company decided to discontinue operating the Healthy Extracts division and did not operate it in 2019. At the time of the closure, the Company incurred a loss for the year of $714 which eliminated all carrying values of assets and liabilities for the division.   Eqova Life Science   On June 1, 2019, the Company decided to discontinue operating the Eqova Life Science division which ceased all activities in May 2019. Due to the closure, the Company incurred a loss for the year of $92,609 which eliminated all carrying values of assets and liabilities for the division.

NOTE 11 – BUSINESS SEGMENT INFORMATION   As of June 30, 2020, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the months ended June 30, 2020.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">CONSOLIDATED</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">HEALTH SUPPLEMENTS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">CORPORATE</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">BergaMet</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">UBN</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">607,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">607,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Cost of Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">216,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">216,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Long-lived Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,260</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Gain (Loss) Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,760,363</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(175,950</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(77,341</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,507,072</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,623</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,425</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198</td><td style="text-align: left"> </td></tr> </table>   The following table presents selected financial information about the Company’s reportable segments for the three months ended June 30, 2020.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold">CONSOLIDATED</td><td style="font-weight: bold"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">HEALTH SUPPLEMENTS</td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold">CORPORATE</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">BergaMet</td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">UBN</td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">151,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">151,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Cost of Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Long-lived Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,260</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Gain (Loss) Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,385,173</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(220,206</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(77,341</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,087,626</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,312</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,213</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99</td><td style="text-align: left"> </td></tr> </table>

NOTE 12 – SUBSEQUENT EVENTS   On May 30, 2020, the Company proposed a stock options agreement in the amount of 10,550,000 shares with a strike price of $0.05 to sixteen individuals.   During August 2020, two of the Company issued convertible debt notes were purchased by third parties totaling $160,000 in company convertible debt. The parties whom purchased these notes came to terms with the Company on the total debt and interest outstanding and agreed to convert those notes to shares in the third quarter of 2020. The total of $213,874 of debt and accrued interest was satisfied with the conversion to 3,400,000 shares.   On August 25, 2020, the Company came to agreement with two of the convertible debt note holders to execute the conversion of the note to shares. The amount converted was $1,129,667 in principal and $491,716 in accrued interest for 32,427,651 shares.   COVID-19   The COVID-19 outbreak in early 2020 has adversely affected, and may continue to adversely affect economic activity globally, nationally and locally. These economic and market conditions and other effects of the COVID-19 outbreak may adversely affect the Company. At this point, the extent to which COVID-19 may impact the Company's business is uncertain.

Basis of Presentation   The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020 and the results of operations and cash flows for the periods presented. The results of operations for the six months ended June 30, 2020 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s form 10-K for the year ended December 31, 2019 filed with the SEC on August 10, 2020.

Use of Estimates   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Cash   Cash includes cash in banks, money market funds, and certificates of term deposits with maturities of less than three months from inception, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value.

Accounts Receivables   Accounts receivables are recorded at the invoice amount and do not bear interest.

Inventory   Inventories consist of health supplements held for sale in the ordinary course of business. The Company uses the weighted average cost method to value its inventories at the lower of cost or market. An allowance for inventory was established in 2018 and is evaluated each quarter to determine if all items are still sellable due to expiration dates. As of June 30, 2020 and 2019, the total of inventory which was written off as an inventory allowance was $748,972 and $324,014.

Property and Equipment   The Company’s property and equipment are recorded at cost and depreciated using the straight-line method over the useful lives of the assets, generally from three to seven years. Upon sale or disposal of property and equipment, the related asset cost and accumulated depreciation or amortization are removed from the respective accounts and any gain or loss is reflected in current operations.

Goodwill   In accordance with Goodwill and Other Intangible Assets, goodwill is defined as the excess of the purchase price over the fair value assigned to individual assets acquired and liabilities assumed and is tested for impairment at the reporting unit level on an annual basis in the Company's fourth fiscal quarter or more frequently if indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair value of the Company's reporting units with each respective reporting unit's carrying amount, including goodwill. The fair value of reporting units is generally determined using the income approach. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the second step of the goodwill impairment test is performed to determine the amount of any impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. The Company sees the goodwill to have a ten-year useful life. No goodwill impairment indicators were present, for the goodwill listed on the books as of March 31, 2020, after working through our analysis of goodwill during the months ending June 30, 2020.   The Company has determined that the method applied represents the fair value of the asset group principally because the valuation of the intangibles with the asset group is based on the anticipated cash flows related to the revenue stream from its customers. The asset group excludes goodwill, long term non-operational assets and liabilities and cash. As such, the principal value from the asset group relates to the cash inflows from its customers and the cash outflows required to service these customers. The fair value for the asset group consists of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of net revenues: computed using the income approach. The key input to these computations is the anticipated cash inflows from customers. These valuations include 100% of the cash inflows related to the customer base, and taking cash outflows into consideration.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of working capital (including accounts receivable, inventory, accrued expenses, and accounts payables). Due to the short-term nature of the working capital, book value has been determined to be fair value. These accounts represent either avoided future outflows (inventory, prepaids) or future cash flows (accrued expense, AP and AR) related to customer sales.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24px; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif">Fair value of five years of revenue (2019 to 2023): we discounted our cash flows to the anticipated cash projected to be received. We also projected the anticipated cash outflows required to service these customers. If the asset group was to be valued as a whole, we would expect an income approach based on the revenues being generated from the customers and expenses required to service those customers, appropriately adjusted for the working capital position. The sum of these values reasonably approximates this approach.</td></tr> </table>   The Company’s revenue streams align directly with the intangibles, which were recorded as a result of the BergaMet acquisition in fiscal 2019. For purposes of the Step 2 recoverability test under ASC 360 subsection 2.3., the net revenues from BergaMet customers base were used. The revenue stream fairly reflects anticipated future cash flows; accordingly, the intangibles associated with these revenue streams have been tested with the expected cash flows.   Due to the purchase of Ultimate Brian Nutrients, LLC being a related party transaction and the new division recording no revenue as of June 30, 2020, the Company found the goodwill to be impaired. Due to the impairment the Company expensed the goodwill related to the purchase as of June 30, 2020.

Revenue Recognition   Beginning January 1, 2019, the Company implemented ASC 606, Revenue from Contracts with Customers.  Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them.  These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures   The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services.  To achieve this core principle, we apply the following five steps:  identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.   The Company records revenue upon shipment of the products to the customers.

Concentration   There is no concentration of revenue for the months ended June 30, 2019 and the months ended June 30, 2020 because the revenue was earned from multiple customers.

Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Accounting for Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. For the period ending December 31, 2019 and June 30, 2020, the Company did not have any amounts recorded pertaining to uncertain tax positions.

Fair Value Measurements   The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.   The estimated fair value of certain financial instruments, including cash and cash equivalents are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.   ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:   Level 1 — quoted prices in active markets for identical assets or liabilities   Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable   Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)   The derivative liability in connection with the conversion feature of the convertible debt, classified as a Level 3 liability, is the only financial liability measure at fair value on a recurring basis.   The change in Level 3 financial instrument is as follows:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; padding-left: 5.4pt">Balance, January 1, 2020</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,060,388</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Issued during the months ended June 30, 2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,668,799</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Change in fair value recognized in operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(593,602</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Converted during the months ended June 30, 2020</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(217,862</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance, June 30, 2020</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,917,723</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Recent Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 amends the guidance for revenue recognition to replace numerous, industry specific requirements and converges areas under this topic with those of the International Financial Reporting Standards. The ASU implements of five–step process for customer contract revenue recognition that focuses on transfer of control, as opposed to transfer of risk and rewards. The amendment also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. Other major provisions include the capitalization and amortization of certain contract cost, ensuring the time value of money is considered in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The amendments in this ASU are effective for reporting period beginning after December 15, 2016, and early adoption is prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption.   The Company’s revenues are recognized when control of the promised goods or services is transferred to our clients (upon shipment of goods) in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: (1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the Company satisfies a performance obligation.   We adopted ASC 2014-09 on January 1, 2019. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities with them.

Convertible Instruments   The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.   Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.   The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.   The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. During the months ended March 31, 2020, the Company did not have any conversions of convertible debt with a bifurcated conversion option.

Common Stock Purchase Warrants   The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC 815-40 ("Contracts in Entity's Own Equity"). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification is required. Gain on Extinguishment of debt   Note Satisfaction Agreements   Prior to the Exchange, the Company entered into a Note Satisfaction Agreement with each of Auctus Fund, Crown Bridge Partners, LLC, Power Up Lending Group Ltd., GS Capital Partners LLC, Oakmore Opportunity Fund I LP, and Adar Bays, LLC. All of these entities were holders of the Company’s convertible debt, and these Note Satisfaction Agreements terminate their convertible notes unless the Company fails to perform its payment obligations. The Company agreed to pay these note holders an aggregate of $520,658 plus interest. The Company paid an aggregate of $353,908 on or before February 15, 2019. The balance owed and outstanding of $160,000 plus interest has not been paid and the two remaining notes are currently in default.   Various other holders of Convertible Promissory Notes agreed to convert their notes for an aggregate of 806,015 shares of common stock prior to the Exchange. As a result of these transactions, no convertible promissory notes remain outstanding, except for those convertible notes subject to revival if the Company fails to make payments pursuant to the Note Satisfaction Agreements.

The change in Level 3 financial instrument is as follows:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; padding-left: 5.4pt">Balance, January 1, 2020</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,060,388</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Issued during the months ended June 30, 2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,668,799</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Change in fair value recognized in operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(593,602</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Converted during the months ended June 30, 2020</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(217,862</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance, June 30, 2020</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,917,723</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; width: 70%; text-align: justify; padding-left: 5.4pt">Unsecured convertible debt, due 01/17/24, 4% interest, converts at $0.05 for a total of 30,604,333 shares</td><td style="padding-bottom: 1pt; width: 10%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right">1,050,000</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,050,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table> As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; text-align: left; padding-left: 5.4pt">Unsecured debt with shareholders of the Company, due 02/04/2020, 4% interest, interest due quarterly.</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">79,667</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Unsecured debt with shareholders of the Company, no due date, 0% interest,</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">866</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">80,533</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

As of June 30, 2020, the Company had the following:   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="width: 70%; text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 11/01/18, 12% interest, converts at a 50% discount to market price based on the last 25 days trading price</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">110,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 02/02/19, 8% interest, converts at a 55% discount to market price based on the last 20 days trading price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Unsecured convertible debt, due 01/19/17, 8% interest, default interest at 18%, converts at a 54% discount to market price based on the lowest trading prices in the last 20 days trading price</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">SUBTOTAL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 5.4pt">Less: Discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">TOTAL</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">166,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

The following table presents selected financial information about the Company’s reportable segments for the months ended June 30, 2020.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">CONSOLIDATED</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">HEALTH SUPPLEMENTS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-weight: bold">CORPORATE</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">BergaMet</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; font-weight: bold">UBN</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">607,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">607,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Cost of Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">216,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">216,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Long-lived Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,260</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Gain (Loss) Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,760,363</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(175,950</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(77,341</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,507,072</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,623</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,425</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198</td><td style="text-align: left"> </td></tr> </table>   The following table presents selected financial information about the Company’s reportable segments for the three months ended June 30, 2020.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold">CONSOLIDATED</td><td style="font-weight: bold"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">HEALTH SUPPLEMENTS</td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold">CORPORATE</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">BergaMet</td><td style="font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">UBN</td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; padding-left: 5.4pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">151,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">151,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">Cost of Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,589</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Long-lived Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,260</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Gain (Loss) Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,385,173</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(220,206</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(77,341</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,087,626</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,072,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,312</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,213</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99</td><td style="text-align: left"> </td></tr></table>

748972

324014

121610085

264059759

1333334

6455354

996 1921 2917 996052

1890020

90001

1800019

97410

1850784

1948194

90000960

97409678

350000

350

6650

7000

52448714

806015

2164408

52449

2111959

806

106912

107718

-1333334

15592986

-1333

15593

-14260

EX-101.SCH 8 grck-20200630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - CONVERTIBLE DEBT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - DISCONTINED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - BUSINESS SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - CONVERTIBLE DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - CONVERTIBLE DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - ACQUISITIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - ACQUISITIONS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - BUSINESS SEGMENT INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 grck-20200630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 grck-20200630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 grck-20200630_lab.xml XBRL LABEL FILE Related Party [Axis] Officer and Director [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 3 [Member] Liability Class [Axis] Liability [Member] Long-term Debt, Type [Axis] Unsecured convertible debt, due 10/04/18 [Member] Unsecured convertible debt, due 11/09/18 [Member] Unsecured convertible debt, due 01/08/19 [Member] Equity Components [Axis] Common Stock Segments [Axis] Corporate Segment [Member] Business Acquisition [Axis] BergaMet [Member] Preferred Stock Additional Paid-In Capital Accumulated Deficit Unsecured convertible debt, due 02/04/2020 [Member] Unsecured convertible debt, due 08/20/18 [Member] Unsecured convertible debt, due 11/01/18 [Member] Unsecured convertible debt, due 02/02/19 [Member] Unsecured convertible debt, due 01/19/17 [Member] Healthy Extracts Eqova Life Science Ultimate Brain Nutrients, LLC [Member] Unsecured convertible debt, due 01/17/24 [Member] Health Supplements [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Entity Shell Company Entity Emerging Growth Company Entity Small Business Entity Ex Transition Period Entity Interactive Data Current Entity Incorporation, State or Country Code Entity File Number Document Quarterly Report Document Annual Report Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Accounts receivable Inventory Total current assets Fixed assets, net of accumulated depreciation of $39,207 and $36,895, respectively Patents/Trademarks Goodwill Total other assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT LIABILITIES CURRENT LIABILITIES Accounts payable Accrued liabilities Notes payable Notes payable - related party Convertible debt, net of discount of $0.00 and $0.00, respectively Convertible debt - related party, net of discount of $0.00 and $0.00, respectively Accrued interest payable Accrued interest payable - related party Derivative liabilities Total current liabilities Total liabilities STOCKHOLDERS' EQUITY Preferred stock, $0.001 par value, 75,000,000 shares authorized, none and none shares issued and outstanding, respectively Common stock, $0.001 par value, 2,500,000,000 shares authorized, 264,059,759 and 121,610,085 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Fixed Assets, net of accumulated depreciation Preferred Stock, Par Value Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares Issued Common Stock, Shares Outstanding Consolidated Statement Of Operations REVENUE COST OF REVENUE GROSS PROFIT OPERATING EXPENSES General and administrative Total operating expenses OTHER INCOME Interest expense, net of interest income Change in fair value of derivative Loss on extinguishment of debt Impairment of Assets Total other income (expense) Net gain/(loss) before income tax provision NET INCOME/(LOSS) Loss per share - basic and diluted Weighted average number of shares outstanding - basic and diluted Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net Income / (Loss) Adjustments to reconcile net loss to net cash used in operating activities: Deprecation and amortization Warrants issued for services Non-cash compensation Change in fair value on derivative liability Changes in operating assets and liabilities: Accounts receivable Inventory Accrued interest receivable Accounts payable Accounts payable - related party Accrued liabilities Accrued interest payable Accrued interest payable - related party Net Cash used in Operating Activities Cash Flows from Investing Activities: Purchase of fixed assets Purchse of note receivable Purchase of BergaMet Purchase of UBN Net Cash used in Investing Activities Cash Flows from Financing Activities: Proceeds from issuance of common stock Proceeds from issuance of convertible debt Payments for repayment of convertible debt Proceds from issuance of noted payable Proceeds from issuance of noted payable - related party Payments for repayment of notes payable - related party Net Cash provided by Financing Activities Increase in cash Cash at beginning of period Cash at end of period Statement [Table] Statement [Line Items] Beginning Balance Beginning Balance, Shares Cashless exercise of warrants Cashless exercise of warrants, Shares Issuance of sharess acquisition Issuance of sharess acquisition, Shares Issuance of common stock for preferred stock conversion Issuance of common stock for preferred stock conversion, Shares Issuance of common stock for debt conversion Issuance of common stock for debt conversion, Shares Issuance of common stock for consulting fees Issuance of common stock for consulting fees, Shares Net (loss) gain for the period Ending Balance Ending Balance, Shares Accounting Policies [Abstract] ORGANIZATION AND DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes to Financial Statements GOING CONCERN Related Party Transactions [Abstract] RELATED PARTY Convertible Debt - Related Party CONVERTIBLE DEBT - RELATED PARTY NOTES PAYABLE Debt Disclosure [Abstract] CONVERTIBLE DEBT Stockholders Equity STOCKHOLDERS' EQUITY Business Combinations [Abstract] ACQUISITIONS DISCONTINED OPERATIONS Business Segment Information BUSINESS SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates Cash Accounts Receivable Inventory Property and Equipment Goodwill Revenue Recognition Concentration EX-101.PRE 12 grck-20200630_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2020	Sep. 14, 2020
Document And Entity Information
Entity Registrant Name	GREY CLOAK TECH INC.
Entity Central Index Key	0001630176
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	No
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		299,887,410
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Entity File Number	000-55572
Document Quarterly Report	true

XML 14 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 664,156	$ 133,451
Accounts receivable	15,862	26,473
Inventory	3,061,796	3,081,158
Total current assets	3,741,814	3,241,083
Fixed assets, net of accumulated depreciation of $39,207 and $36,895, respectively	10,560	15,183
Patents/Trademarks	336,891
Goodwill	193,260	193,260
Total other assets	540,711	208,443
TOTAL ASSETS	4,282,525	3,449,526
CURRENT LIABILITIES
Accounts payable	44,270	21,125
Accrued liabilities	54,122	53,341
Notes payable	79,667	79,667
Notes payable - related party	1,050,866	1,050,866
Convertible debt, net of discount of $0.00 and $0.00, respectively	166,750	166,750
Convertible debt - related party, net of discount of $0.00 and $0.00, respectively		1,341,876
Accrued interest payable	60,455	49,902
Accrued interest payable - related party	480,217	491,221
Derivative liabilities	1,917,723	1,060,388
Total current liabilities	3,854,070	4,315,136
Total liabilities	3,854,070	4,315,136
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 75,000,000 shares authorized, none and none shares issued and outstanding, respectively
Common stock, $0.001 par value, 2,500,000,000 shares authorized, 264,059,759 and 121,610,085 shares issued and outstanding, respectively	264,060	121,610
Additional paid-in capital	13,304,881	9,392,903
Accumulated deficit	(13,140,485)	(10,380,123)
Total stockholders' equity	428,456	(865,610)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 4,282,525	$ 3,449,526

XML 15 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Fixed Assets, net of accumulated depreciation	$ 39,207	$ 36,895
Preferred Stock, Par Value	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	75,000,000	75,000,000
Preferred Stock, Shares Issued
Preferred Stock, Shares Outstanding
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	2,500,000,000	2,500,000,000
Common Stock, Shares Issued	264,059,759	121,610,085
Common Stock, Shares Outstanding	264,059,759	121,610,085

XML 16 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Consolidated Statement Of Operations
REVENUE	$ 151,719	$ 201,040	$ 607,558	$ 298,313
COST OF REVENUE	20,589	46,241	216,646	78,004
GROSS PROFIT	131,130	154,799	390,912	220,308
OPERATING EXPENSES
General and administrative	444,318	300,109	651,950	562,625
Total operating expenses	444,318	300,109	651,950	562,625
OTHER INCOME
Interest expense, net of interest income	(19,631)	(19,675)	(62,107)	(32,539)
Change in fair value of derivative	(1,472,471)	(113,407)	(857,335)	1,636,029
Loss on extinguishment of debt				53,038
Impairment of Assets	(1,579,883)		(1,579,883)
Total other income (expense)	(3,071,985)	(133,082)	(2,499,325)	1,656,528
Net gain/(loss) before income tax provision	(3,385,173)	(278,392)	(2,760,363)	1,314,212
NET INCOME/(LOSS)	$ (3,385,173)	$ (278,392)	$ (2,760,363)	$ 1,314,212
Loss per share - basic and diluted	$ (0.02)	$ 0	$ (0.01)	$ 0.01
Weighted average number of shares outstanding - basic and diluted	182,890,767	98,883,192	223,697,036	110,612,376

XML 17 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash Flows from Operating Activities:
Net Income / (Loss)	$ (2,760,363)	$ 1,314,212
Adjustments to reconcile net loss to net cash used in operating activities:
Deprecation and amortization	4,623	1,614
Warrants issued for services		7,000
Non-cash compensation		108,260
Change in fair value on derivative liability	857,335	(1,941,315)
Loss on extinguishment of debt		53,038
Changes in operating assets and liabilities:
Accounts receivable	10,611	(27,157)
Inventory	19,362	(2,343,328)
Accrued interest receivable		4,762
Accounts payable	23,145	(11,240)
Accounts payable - related party		(15,000)
Accrued liabilities	781
Accrued interest payable	10,553	393,558
Accrued interest payable - related party	(11,004)	769
Net Cash used in Operating Activities	(1,844,956)	(2,176,435)
Cash Flows from Investing Activities:
Purchase of fixed assets		(22,985)
Purchse of note receivable		79,295
Purchase of BergaMet		1,907,010
Purchase of UBN	(336,891)	1,907,010
Net Cash used in Investing Activities	(336,891)	3,870,331
Cash Flows from Financing Activities:
Proceeds from issuance of common stock	4,054,428
Proceeds from issuance of convertible debt	(1,341,876)	(71,092)
Payments for repayment of convertible debt		(349,330)
Proceds from issuance of noted payable		(63,000)
Proceeds from issuance of noted payable - related party		1,050,700
Payments for repayment of notes payable - related party		(15,000)
Net Cash provided by Financing Activities	2,712,552	552,278
Increase in cash	530,705	2,246,175
Cash at beginning of period	133,451	485
Cash at end of period	$ 664,156	$ 2,246,660

XML 18 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance at Dec. 31, 2018	$ 1,333	$ 6,455	$ 7,440,895	$ (11,012,899)	$ (3,564,216)
Beginning Balance, Shares at Dec. 31, 2018	1,333,334	6,455,354
Cashless exercise of warrants		$ 996	1,921		2,917
Cashless exercise of warrants, Shares		996,052
Issuance of sharess acquisition		$ 97,410	1,850,784		1,948,194
Issuance of sharess acquisition, Shares		97,409,678
Issuance of common stock for preferred stock conversion	$ (1,333)	$ 15,593	(14,260)
Issuance of common stock for preferred stock conversion, Shares	(1,333,334)	15,592,986
Issuance of common stock for debt conversion		$ 806	106,912		107,718
Issuance of common stock for debt conversion, Shares		806,015
Issuance of common stock for consulting fees		$ 350	6,650		7,000
Issuance of common stock for consulting fees, Shares		350,000
Net (loss) gain for the period				632,776	632,776
Ending Balance at Dec. 31, 2019		$ 121,610	9,392,903	(10,380,123)	(865,610)
Ending Balance, Shares at Dec. 31, 2019		121,610,085
Issuance of sharess acquisition		$ 90,001	1,800,019		1,890,020
Issuance of sharess acquisition, Shares		90,000,960
Issuance of common stock for debt conversion		$ 52,449	2,111,959		2,164,408
Issuance of common stock for debt conversion, Shares		52,448,714
Net (loss) gain for the period				(2,760,363)	(2,760,363)
Ending Balance at Jun. 30, 2020		$ 264,060	$ 13,304,881	$ (13,140,485)	$ 428,456
Ending Balance, Shares at Jun. 30, 2020		264,059,759

XML 19 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND DESCRIPTION OF BUSINESS

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

XML 20 R8.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Cash

Accounts Receivables

Accounts receivables are recorded at the invoice amount and do not bear interest.

Inventory

Property and Equipment

Goodwill

	•	Fair value of net revenues: computed using the income approach. The key input to these computations is the anticipated cash inflows from customers. These valuations include 100% of the cash inflows related to the customer base, and taking cash outflows into consideration.

	•	Fair value of working capital (including accounts receivable, inventory, accrued expenses, and accounts payables). Due to the short-term nature of the working capital, book value has been determined to be fair value. These accounts represent either avoided future outflows (inventory, prepaids) or future cash flows (accrued expense, AP and AR) related to customer sales.

	•	Fair value of five years of revenue (2019 to 2023): we discounted our cash flows to the anticipated cash projected to be received. We also projected the anticipated cash outflows required to service these customers. If the asset group was to be valued as a whole, we would expect an income approach based on the revenues being generated from the customers and expenses required to service those customers, appropriately adjusted for the working capital position. The sum of these values reasonably approximates this approach.

Revenue Recognition

The Company records revenue upon shipment of the products to the customers.

Concentration

There is no concentration of revenue for the months ended June 30, 2019 and the months ended June 30, 2020 because the revenue was earned from multiple customers.

Income Taxes

Fair Value Measurements

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

The change in Level 3 financial instrument is as follows:

Balance, January 1, 2020	$	1,060,388
Issued during the months ended June 30, 2020		1,668,799
Change in fair value recognized in operations		(593,602	)
Converted during the months ended June 30, 2020		(217,862	)
Balance, June 30, 2020	$	1,917,723

Recent Accounting Pronouncements

Convertible Instruments

The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Common Stock Purchase Warrants

Gain on Extinguishment of debt

Note Satisfaction Agreements

XML 21 R9.htm IDEA: XBRL DOCUMENT

GOING CONCERN

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

GOING CONCERN

NOTE 3 – GOING CONCERN

XML 22 R10.htm IDEA: XBRL DOCUMENT

RELATED PARTY

6 Months Ended

Jun. 30, 2020

RELATED PARTY

NOTE 4 – RELATED PARTY

XML 23 R11.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT - RELATED PARTY

6 Months Ended

Jun. 30, 2020

Convertible Debt - Related Party

CONVERTIBLE DEBT - RELATED PARTY

NOTE 5 – CONVERTIBLE DEBT – RELATED PARTY

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 01/17/24, 4% interest, converts at $0.05 for a total of 30,604,333 shares			1,050,000
TOTAL		$	1,050,000

As of June 30, 2020, the Company has an outstanding total of $480,213 in accrued interest for the above convertible notes.

Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:

Payee		Number of options valued				Value of Convertible Option
Unsecured Convertible debt #1			30,604,333			$	1,668,799

XML 24 R12.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

As of June 30, 2020, the Company had the following:

Unsecured debt with shareholders of the Company, due 02/04/2020, 4% interest, interest due quarterly.		79,667
Unsecured debt with shareholders of the Company, no due date, 0% interest,		866
TOTAL	$	80,533

As of June 30, 2020, the Company has an outstanding total of $4,479 in accrued interest for the above note and past obligations which are unpaid.

XML 25 R13.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

CONVERTIBLE DEBT

NOTE 7 – CONVERTIBLE DEBT

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 11/01/18, 12% interest, converts at a 50% discount to market price based on the last 25 days trading price		110,000
Unsecured convertible debt, due 02/02/19, 8% interest, converts at a 55% discount to market price based on the last 20 days trading price		50,000
Unsecured convertible debt, due 01/19/17, 8% interest, default interest at 18%, converts at a 54% discount to market price based on the lowest trading prices in the last 20 days trading price		6,750

SUBTOTAL		166,750
Less: Discount		—
TOTAL	$	166,750

Below represent the Black-Scholes Option Pricing Model calculations for the above convertible note payables:

Payee	Number of options valued		Value of Convertible Option
Unsecured Convertible debt #1		6,044,465	$	181,531
Unsecured Convertible debt #2		2,136,272	$	58,916
Unsecured Convertible debt #3		312,896	$	8,477

As of June 30, 2020, the Company has an outstanding total of $55,976 in accrued interest for the above convertible notes.

Two of the convertible promissory notes feel into default during the first quarter of 2020, but we have been able to secure an extension for repayment on one of the two notes which will be August 1st, 2020. We are in talks with the other party to extend the other note. With the note still being negotiated, we have calculated the derivative liability as if it is in default (but the note’s default interest rate stays the same at 8%) and will still accrue appropriate interest until the note is fully satisfied or converted into the Company’s common stock.

XML 26 R14.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY

6 Months Ended

Jun. 30, 2020

Stockholders Equity

STOCKHOLDERS' EQUITY

NOTE 8 – STOCKHOLDERS’ EQUITY

Authorized Stock

As of June 30, 2020, there are no outstanding shares of preferred stock. All the preferred stock was converted into common stock on February 4, 2019. See recent developments for details.

Common Share Issuances

Warrant Issuances

As of June 30, 2020, there were 16,800 warrants outstanding, of which 8,800 warrants are fully vested.

Stock Issued for Services

Share Conversion Agreements

XML 27 R15.htm IDEA: XBRL DOCUMENT

ACQUISITIONS

6 Months Ended

Jun. 30, 2020

Business Combinations [Abstract]

ACQUISITIONS

NOTE 9 – ACQUISITIONS

Acquisition of Ultimate Brain Nutrients, LLC

Cash	$	(5,466	)
Current assets		315,604
Current liabilities		0
Net assets acquired	$	310,137

Acquisition of BergaMet and the Share Exchange Agreement

Cash	$	437,826
Current assets		2,801,317
Current liabilities		(1,484,210	)
Net assets acquired	$	1,754,934

XML 28 R16.htm IDEA: XBRL DOCUMENT

DISCONTINED OPERATIONS

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

DISCONTINED OPERATIONS

NOTE 10 – DISCOUNTINUED OPERATIONS

Healthy Extracts

Eqova Life Science

XML 29 R17.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2020

Business Segment Information

BUSINESS SEGMENT INFORMATION

NOTE 11 – BUSINESS SEGMENT INFORMATION

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		607,558			607,558			—			—
Cost of Revenue		216,646			216,646			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(2,760,363	)		(175,950	)		(77,341	)		(2,507,072	)
Identifiable Assets		3,072,356			3,072,356			—			—
Depreciation and Amortization		4,623			4,425			—			198

The following table presents selected financial information about the Company’s reportable segments for the three months ended June 30, 2020.

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		151,719			151,719			—			—
Cost of Revenue		20,589			20,589			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(3,385,173	)		(220,206	)		(77,341	)		(3,087,626	)
Identifiable Assets		3,072,356			3,072,356			—			0
Depreciation and Amortization		2,312			2,213			—			99

XML 30 R18.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2020

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 12 – SUBSEQUENT EVENTS

On May 30, 2020, the Company proposed a stock options agreement in the amount of 10,550,000 shares with a strike price of $0.05 to sixteen individuals.

COVID-19

XML 31 R19.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Use of Estimates

Use of Estimates

Cash

Cash

Accounts Receivable

Accounts Receivables

Accounts receivables are recorded at the invoice amount and do not bear interest.

Inventory

Inventory

Property and Equipment

Property and Equipment

Goodwill

Goodwill

	•	Fair value of net revenues: computed using the income approach. The key input to these computations is the anticipated cash inflows from customers. These valuations include 100% of the cash inflows related to the customer base, and taking cash outflows into consideration.

	•	Fair value of working capital (including accounts receivable, inventory, accrued expenses, and accounts payables). Due to the short-term nature of the working capital, book value has been determined to be fair value. These accounts represent either avoided future outflows (inventory, prepaids) or future cash flows (accrued expense, AP and AR) related to customer sales.

	•	Fair value of five years of revenue (2019 to 2023): we discounted our cash flows to the anticipated cash projected to be received. We also projected the anticipated cash outflows required to service these customers. If the asset group was to be valued as a whole, we would expect an income approach based on the revenues being generated from the customers and expenses required to service those customers, appropriately adjusted for the working capital position. The sum of these values reasonably approximates this approach.

Revenue Recognition

Revenue Recognition

The Company records revenue upon shipment of the products to the customers.

Concentration

Concentration

There is no concentration of revenue for the months ended June 30, 2019 and the months ended June 30, 2020 because the revenue was earned from multiple customers.

Income Taxes

Income Taxes

Fair Value Measurements

Fair Value Measurements

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

The change in Level 3 financial instrument is as follows:

Balance, January 1, 2020	$	1,060,388
Issued during the months ended June 30, 2020		1,668,799
Change in fair value recognized in operations		(593,602	)
Converted during the months ended June 30, 2020		(217,862	)
Balance, June 30, 2020	$	1,917,723

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Convertible Instruments

Convertible Instruments

The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Common Stock Purchase Warrants

Common Stock Purchase Warrants

Gain on Extinguishment of debt

Gain on Extinguishment of debt

Note Satisfaction Agreements

XML 32 R20.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Schedule of Fair Value of Financial Liability on Recurring Basis

The change in Level 3 financial instrument is as follows:

Balance, January 1, 2020	$	1,060,388
Issued during the months ended June 30, 2020		1,668,799
Change in fair value recognized in operations		(593,602	)
Converted during the months ended June 30, 2020		(217,862	)
Balance, June 30, 2020	$	1,917,723

XML 33 R21.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT - RELATED PARTY (Tables)

6 Months Ended

Jun. 30, 2020

Disclosure Convertible Debt Related Party Tables Abstract

Schedule of Convertible Notes - Related Party

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 01/17/24, 4% interest, converts at $0.05 for a total of 30,604,333 shares			1,050,000
TOTAL		$	1,050,000

XML 34 R22.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Tables)

6 Months Ended

Jun. 30, 2020

Notes Payable

Schedule of Notes Payable

As of June 30, 2020, the Company had the following:

Unsecured debt with shareholders of the Company, due 02/04/2020, 4% interest, interest due quarterly.		79,667
Unsecured debt with shareholders of the Company, no due date, 0% interest,		866
TOTAL	$	80,533

XML 35 R23.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT (Tables)

6 Months Ended

Jun. 30, 2020

Convertible Debt

Schedule of Convertible Debt

As of June 30, 2020, the Company had the following:

Unsecured convertible debt, due 11/01/18, 12% interest, converts at a 50% discount to market price based on the last 25 days trading price		110,000
Unsecured convertible debt, due 02/02/19, 8% interest, converts at a 55% discount to market price based on the last 20 days trading price		50,000
Unsecured convertible debt, due 01/19/17, 8% interest, default interest at 18%, converts at a 54% discount to market price based on the lowest trading prices in the last 20 days trading price		6,750

SUBTOTAL		166,750
Less: Discount		—
TOTAL	$	166,750

XML 36 R24.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Tables)

6 Months Ended

Jun. 30, 2020

Ultimate Brain Nutrients, LLC [Member]

Schedule of fair value of Assets Acquired and Fair value Assumed

The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.

Cash	$	(5,466	)
Current assets		315,604
Current liabilities		0
Net assets acquired	$	310,137

BergaMet [Member]

Schedule of fair value of Assets Acquired and Fair value Assumed

The following table summarizes the fair values assigned to the assets acquired and liabilities assumed.

Cash	$	437,826
Current assets		2,801,317
Current liabilities		(1,484,210	)
Net assets acquired	$	1,754,934

XML 37 R25.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2020

Disclosure Business Segment Informationition Tables Abstract

Schedule of Reportable segments

The following table presents selected financial information about the Company’s reportable segments for the months ended June 30, 2020.

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		607,558			607,558			—			—
Cost of Revenue		216,646			216,646			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(2,760,363	)		(175,950	)		(77,341	)		(2,507,072	)
Identifiable Assets		3,072,356			3,072,356			—			—
Depreciation and Amortization		4,623			4,425			—			198

The following table presents selected financial information about the Company’s reportable segments for the three months ended June 30, 2020.

	CONSOLIDATED			HEALTH SUPPLEMENTS						CORPORATE
				BergaMet			UBN
Revenue		151,719			151,719			—			—
Cost of Revenue		20,589			20,589			—			—
Long-lived Assets		530,151			—			336,891			193,260
Gain (Loss) Before Income Tax		(3,385,173	)		(220,206	)		(77,341	)		(3,087,626	)
Identifiable Assets		3,072,356			3,072,356			—			0
Depreciation and Amortization		2,312			2,213			—			99

XML 38 R26.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Jun. 30, 2020 USD ($)
Beginning Balance	$ 1,060,388
Ending Balance	1,917,723
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member] \| Liability [Member]
Beginning Balance	1,060,388
Issued During the Period	1,668,799
Change in fair value recognized in operations	(593,602)
Converted During the Period	(217,862)
Ending Balance	$ 1,917,723

XML 39 R27.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Summary Of Significant Accounting Policies
Inventory Allowance Written Down	$ 748,972	$ 324,014

XML 40 R28.htm IDEA: XBRL DOCUMENT

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Notes to Financial Statements
Accumulated Net Loss	$ 13,140,485	$ 10,380,123

XML 41 R29.htm IDEA: XBRL DOCUMENT

RELATED PARTY (Details Narrative) - USD ($)	6 Months Ended
RELATED PARTY (Details Narrative) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Convertible Debt			$ 1,341,876
Accured Interest Payable	480,217		$ 491,221
Officer and Director [Member]
General and administrative - Salaries	80,000	$ 24,000
Convertible Debt	1,050,866
Accured Interest Payable	$ 480,217

XML 42 R30.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT - RELATED PARTY (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Convertible debt - related party		$ 1,341,876
Unsecured convertible debt, due 01/17/24 [Member]
Convertible debt - related party	$ 1,050,000
Interest rate	4.00%
Due date of Loan	Jan. 17, 2024

XML 43 R31.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Details Narrative)	6 Months Ended
NOTES PAYABLE (Details Narrative)	Jun. 30, 2020 USD ($)
Unsecured convertible debt, due 02/04/2020 [Member]
Notes Payable	$ 79,667
Interest rate	4.00%
Due date of Loan	Feb. 04, 2020
Unsecured convertible debt, due 08/20/18 [Member]
Notes Payable	$ 866

XML 44 R32.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT (Details Narrative) - USD ($)	6 Months Ended
CONVERTIBLE DEBT (Details Narrative) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Convertible promissory note	$ 166,750
Convertible promissory note, discount
TOTAL	166,750	$ 166,750
Unsecured convertible debt, due 10/04/18 [Member]
Convertible promissory note	$ 110,000
Interest rate	12.00%
Due date of Loan	Nov. 01, 2018
Debt Instrument, Interest Rate, Increase (Decrease)	50.00%
Unsecured convertible debt, due 11/09/18 [Member]
Convertible promissory note	$ 50,000
Interest rate	8.00%
Due date of Loan	Feb. 02, 2019
Debt Instrument, Interest Rate, Increase (Decrease)	55.00%
Unsecured convertible debt, due 01/08/19 [Member]
Convertible promissory note	$ 6,750
Interest rate	8.00%
Due date of Loan	Jan. 19, 2017
Debt Instrument, Interest Rate, Increase (Decrease)	18.00%

XML 45 R33.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Details) - shares	Apr. 03, 2020	Feb. 04, 2019
Preferred Shares Issued, Shares
Ultimate Brain Nutrients, LLC [Member]
Preferred Shares Issued, Shares	90,000,960
BergaMet [Member]
Preferred Shares Issued, Shares		97,409,678

XML 46 R34.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Details 2) - USD ($)	Apr. 03, 2020	Feb. 04, 2019
Ultimate Brain Nutrients, LLC [Member]
Cash	$ (5,466)
Current assets	315,604
Current liabilities	0
Net assets acquired	$ 310,137
BergaMet [Member]
Cash		$ 437,826
Current assets		2,801,317
Current liabilities		(1,484,210)
Net assets acquired		$ 1,754,934

XML 47 R35.htm IDEA: XBRL DOCUMENT

DISCONTINUED OPERATIONS (Details Narrative)	6 Months Ended
DISCONTINUED OPERATIONS (Details Narrative)	Jun. 30, 2020 USD ($)
Healthy Extracts
Net Loss for the Year	$ 714
Eqova Life Science
Net Loss for the Year	$ 92,609

- Definition

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

XML 48 R36.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT INFORMATION (Details) - USD ($)	3 Months Ended		6 Months Ended
BUSINESS SEGMENT INFORMATION (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue	$ 151,719	$ 201,040	$ 607,558	$ 298,313
Cost of Revenue	20,589	46,241	216,646	78,004
Long-lived Assets	193,260		193,260
Loss Before Income Tax	(3,385,173)	$ (278,392)	(2,760,363)	1,314,212
Identifiable Assets	3,072,356		3,072,356
Depreciation and Amortization	2,312		4,623	$ 1,614
Health Supplements [Member] \| BergaMet [Member]
Revenue	151,719		607,558
Cost of Revenue	20,589		216,646
Long-lived Assets
Loss Before Income Tax	(220,206)		(175,950)
Identifiable Assets	3,072,356		3,072,356
Depreciation and Amortization	2,213		4,425
Health Supplements [Member] \| Ultimate Brain Nutrients, LLC [Member]
Revenue
Cost of Revenue
Long-lived Assets	336,891		336,891
Loss Before Income Tax	(77,341)		(77,341)
Identifiable Assets
Depreciation and Amortization
Corporate Segment [Member]
Revenue
Cost of Revenue
Long-lived Assets	530,151		530,151
Loss Before Income Tax	(3,087,626)		(2,507,072)
Identifiable Assets	0
Depreciation and Amortization	$ 99		$ 198

EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 62 235 1 false 20 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://greycloaktech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://greycloaktech.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://greycloaktech.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) Sheet http://greycloaktech.com/role/ConsolidatedStatementOfOperations CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Sheet http://greycloaktech.com/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) Sheet http://greycloaktech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://greycloaktech.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://greycloaktech.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://greycloaktech.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - RELATED PARTY Sheet http://greycloaktech.com/role/RelatedParty RELATED PARTY Notes 10 false false R11.htm 00000011 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY Sheet http://greycloaktech.com/role/ConvertibleDebt-RelatedParty CONVERTIBLE DEBT - RELATED PARTY Notes 11 false false R12.htm 00000012 - Disclosure - NOTES PAYABLE Notes http://greycloaktech.com/role/NotesPayable NOTES PAYABLE Notes 12 false false R13.htm 00000013 - Disclosure - CONVERTIBLE DEBT Sheet http://greycloaktech.com/role/ConvertibleDebt CONVERTIBLE DEBT Notes 13 false false R14.htm 00000014 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://greycloaktech.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 14 false false R15.htm 00000015 - Disclosure - ACQUISITIONS Sheet http://greycloaktech.com/role/Acquisitions ACQUISITIONS Notes 15 false false R16.htm 00000016 - Disclosure - DISCONTINED OPERATIONS Sheet http://greycloaktech.com/role/DiscontinedOperations DISCONTINED OPERATIONS Notes 16 false false R17.htm 00000017 - Disclosure - BUSINESS SEGMENT INFORMATION Sheet http://greycloaktech.com/role/BusinessSegmentInformation BUSINESS SEGMENT INFORMATION Notes 17 false false R18.htm 00000018 - Disclosure - SUBSEQUENT EVENTS Sheet http://greycloaktech.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://greycloaktech.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY (Tables) Sheet http://greycloaktech.com/role/ConvertibleDebt-RelatedPartyTables CONVERTIBLE DEBT - RELATED PARTY (Tables) Tables http://greycloaktech.com/role/ConvertibleDebt-RelatedParty 21 false false R22.htm 00000022 - Disclosure - NOTES PAYABLE (Tables) Notes http://greycloaktech.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://greycloaktech.com/role/NotesPayable 22 false false R23.htm 00000023 - Disclosure - CONVERTIBLE DEBT (Tables) Sheet http://greycloaktech.com/role/ConvertibleDebtTables CONVERTIBLE DEBT (Tables) Tables http://greycloaktech.com/role/ConvertibleDebt-RelatedParty 23 false false R24.htm 00000024 - Disclosure - ACQUISITIONS (Tables) Sheet http://greycloaktech.com/role/AcquisitionsTables ACQUISITIONS (Tables) Tables http://greycloaktech.com/role/Acquisitions 24 false false R25.htm 00000025 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables) Sheet http://greycloaktech.com/role/BusinessSegmentInformationTables BUSINESS SEGMENT INFORMATION (Tables) Tables http://greycloaktech.com/role/BusinessSegmentInformation 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://greycloaktech.com/role/SummaryOfSignificantAccountingPoliciesTables 27 false false R28.htm 00000028 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://greycloaktech.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://greycloaktech.com/role/GoingConcern 28 false false R29.htm 00000029 - Disclosure - RELATED PARTY (Details Narrative) Sheet http://greycloaktech.com/role/RelatedPartyDetailsNarrative RELATED PARTY (Details Narrative) Details http://greycloaktech.com/role/RelatedParty 29 false false R30.htm 00000030 - Disclosure - CONVERTIBLE DEBT - RELATED PARTY (Details Narrative) Sheet http://greycloaktech.com/role/ConvertibleDebt-RelatedPartyDetailsNarrative CONVERTIBLE DEBT - RELATED PARTY (Details Narrative) Details http://greycloaktech.com/role/ConvertibleDebt-RelatedPartyTables 30 false false R31.htm 00000031 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://greycloaktech.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://greycloaktech.com/role/NotesPayableTables 31 false false R32.htm 00000032 - Disclosure - CONVERTIBLE DEBT (Details Narrative) Sheet http://greycloaktech.com/role/ConvertibleDebtDetailsNarrative CONVERTIBLE DEBT (Details Narrative) Details http://greycloaktech.com/role/ConvertibleDebt-RelatedPartyTables 32 false false R33.htm 00000033 - Disclosure - ACQUISITIONS (Details) Sheet http://greycloaktech.com/role/AcquisitionsDetails ACQUISITIONS (Details) Details http://greycloaktech.com/role/AcquisitionsTables 33 false false R34.htm 00000034 - Disclosure - ACQUISITIONS (Details 2) Sheet http://greycloaktech.com/role/AcquisitionsDetails2 ACQUISITIONS (Details 2) Details http://greycloaktech.com/role/AcquisitionsTables 34 false false R35.htm 00000035 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative) Sheet http://greycloaktech.com/role/DiscontinuedOperationsDetailsNarrative DISCONTINUED OPERATIONS (Details Narrative) Details 35 false false R36.htm 00000036 - Disclosure - BUSINESS SEGMENT INFORMATION (Details) Sheet http://greycloaktech.com/role/BusinessSegmentInformationDetails BUSINESS SEGMENT INFORMATION (Details) Details http://greycloaktech.com/role/BusinessSegmentInformationTables 36 false false All Reports Book All Reports grck-20200630.xml grck-20200630.xsd grck-20200630_cal.xml grck-20200630_def.xml grck-20200630_lab.xml grck-20200630_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 54 0001520138-20-000428-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001520138-20-000428-xbrl.zip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end